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Localized cooling is often used to manage both acute and chronic phases of soft tissue 
injuries by reducing pain, swelling, and inflammation. Cold application would result in a decline 
in skin temperature and reduction of blood perfusion at the treatment site. In some instances, the 
use of cryotherapy has been associated with tissue necrosis and nerve damage.  Tissue damage 
was shown to be due to both the direct effect of cooling as well as tissue ischemia resulting from 
the reduced blood perfusion. The purpose of this research was to examine the effect of localized 
cooling on skin temperature and blood perfusion and to develop a method to stimulate blood 
perfusion in tissue following development of cold-induced vasoconstriction. Out of various 
methods used, thermal stimulation was shown to successfully increase tissue perfusion during 
cryotherapy experiments.  
As a part of this research, tissue response to localized cooling was quantified for each of 
a variety of cryotherapy units (CTU).  Moreover, diverse methods were implemented to 
investigate and quantify the non-uniformity of surface temperature for multiple cooling pads in 
combinations with their brand-specific CTUs. It was demonstrated through further studies and 
tissue blood perfusion comparisons (caused by using different CTUs) that there were no 
significant differences between studied units. Additionally, no significant difference was 
observed between knee and ankle/foot in their vasocosnstrictive response to cooling. Using 
multiple statistical methods, it was illustrated that a significant degree of vasoconstriciton 
 vii 
occurred that lasted well beyond the active cooling period while skin temperature had increased 
significantly. Furthermore, a hysteresis effect was observed between skin perfusion and 
temperature during cooling and rewarming periods. In addition, a dose-dependent response in 
skin perfusion in relation to applied temperature was reported. A hysteresis effect between the 
skin temperature and perfusion was observed for both cooling and warming experiments and the 
area of the hysteresis plot was shown to be linearly dependent on applied temperature. Moreover, 
non-uniformity of skin temperature during cryotherapy was noted, which was independent of pad 
temperature distribution.  
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Chapter 1: Introduction 
Cryotherapy is the application of cold for therapeutic purposes. Anything from 
holding a burnt body part under the cold running water to direct application of ice to 
injured tissue and the thermal ablation of tissue by applying below freezing temperatures 
is considered cryotherapy. Localized cooling for clinical applications dates back to 
ancient times. Cryotherapy was used by ancient Egyptians to treat injuries and 
inflammation [1]. In 19
th
 century localized cooling was used for pain management and as 
a skin anesthetics [1,2]. In late 19
th
 century, cryotherapy was used in conjunction with 
surgical procedures. But it was not until mid 20
th
 century that the effect of cooling on 
different tissue responses; like, bleeding, inflammation, and swelling, was studied. 
Around this time cryokinetics was introduced. Cryokinetics combines active exercises 
with localized cooling. It takes advantage of numbing effect of cooling and increase in 
tissue perfusion and lymph removal due to active movements [3].  
Cooling has an analgesic effect by slowing the nerve conduction velocity [4,5], 
and relieve of muscle spasm. It might also function by affecting the nerve endings 
directly [6] and by increasing the pain threshold [5]. The vascular disturbances caused by 
original injury impose further trauma on tissue by reducing the availability of O2 and 
nutrients. By lowering the metabolic need of tissue, cooling counteracts this effect and 
therefore reduces the occurrence of secondary hypoxic injury [3]. Cooling is commonly 
used in soft tissue injury in combination with rest, compression and elevation to minimize 
inflammation. Its anti-inflammatory action might be due to reduction of secondary 
hypoxic injury and resulted release of inflammatory agents from the cells [7]. The 
reduction of swelling can be due to reduced vascular permeability. This effect will be 
canceled out by increase in permeability of lymphatics when tissue temperatures reaches 
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about 15˚C [8].  The bleeding decreases by application of cold due to induction of 
vasoconstriction [9].Cryotherapy is used by athletic trainers and physical therapists in 
both acute and chronic phase of injury. In the acute phase possibly its most important 
functionality is to reduce secondary hypoxic injury, pain and swelling; in the chronic 
phase it helps with reducing the sensation of pain so that the early mobilization would be 
possible. Cryotherapy is commonly used in conjunction with surgical procedures, 
specially, orthopedics surgeries. However, in contrast to its therapeutic benefits, 
cryotherapy also presents a risk factor for causing ischemic-induced injuries such as 
nerve palsy [10–12] and tissue necrosis [13,14].  
Since the cryotherapy complications are related to the tissue temperature as well 
as the reduction in tissue perfusion, understanding the physiological response in the form 
of skin temperature and perfusion are essential to better apprehend the possible effects of 
cryotherapy in tissue. This improved knowledge of cryotherapy effect in tissue could 
result in modifying the cryotherapy practices and modalities such that the healing is 
accelerated and the chance of complications is reduced. I begin this review by 
introducing the common modes of cryotherapy application and recommendations for 
duration of applications and desired thermal condition. Next I will briefly discuss the 
current understanding of vascular response to localized cooling and the possible modes of 
injury in tissue following cold application. Then I will continue by introducing possible 
modalities to stimulate tissue blood flow in the vasoconstricted region following the cold 
application. 
1.1 MODES OF CRYOTHERAPY 
There are many alternative schemes for effecting cold therapy to soft tissue, such 
as crushed ice [15], ice bags [7], cold gel packs [16], and, in particular, cryotherapy units 
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(CTU) that can provide a continuous or intermittent circulation of ice water from an 
insulated container to a pliable cooling pad placed onto the treatment area [13,15,17–21]. 
Local cooling is sometimes combined with complementary therapeutic modalities such as 
transient tissue compression [17,22]. Powered CTUs that feature the capability for 
continuous circulation of cold water have facilitated the ability to sustain extended 
periods of cold therapy measured in hours and days. 
The components of a CTU system typically consist of an insulated chest that is 
filled with ice and water, a submersible pump, a cooling pad that is applied to the 
treatment area, and insulated tubing that connects the pump to the pad in a closed ice 
water circulation loop. The cooling pad generally embodies a flexible polymeric bladder 
with molded conduits through which water is pumped via inlet and outlet ports. An 
example of such devices is presented in Figure 1.1. The user is instructed to fill the ice 
chest with water and ice according to the manufacturer’s recommendations and apply the 
bladder on the surface of interest over some form of insulating layers and holds it in place 
using Ace bandage or a similar product. These devices do not provide any form of 
feedback to the user and for the most part they re-circulate ice-cold water through the 
system. 
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Figure 1.1 A sample cryotherapy device 
1.2 CRYOTHERAPY PRACTICES 
No single thermal application cryotherapy protocol has been identified that 
provides an optimum risk/benefit ratio, resulting in a broad spectrum of cryotherapy 
practices reported in the literature [23,24]. Cryotherapy protocols are generally defined in 
terms of temperature and duration of application and may be run either continuously or 
with temporal modulation. Recommendations for the duration of application vary from 
minutes [7,8] to days [9,19,25]. It is claimed that skin temperature must drop below 
13.6°C (56.5°F) to realize the analgesic effect of cryotherapy and that a 50% reduction in 
tissue metabolism requires tissue temperatures in the range of 10-11°C (50-51.8°F) [26]. 
Moreover, the ability of hemoglobin to release bound oxygen strongly relates to 
temperature, and below about 12°C (53.6°F) the residence time of blood flowing through 
capillaries is shorter than the time constant for oxygen dissociation [27,28]. This 
condition could result in the creation of tissue hypoxia that may also be exacerbated by 
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ischemia. In summary, the level of temperature produced by cryotherapy may affect 
multiple aspects of the procedure outcome.  
1.3 MANUFACTURER’S RECOMMENDATIONS 
CTU Manufacturers provide user instructions that commonly relate to a target 
operating temperature but include a paucity of specific implementation guidelines. 
Alternatively, the responsibility for defining a thermal treatment protocol may be 
assigned to health care providers. The following are examples of temperature-related 
instructions provided with CTUs. DeRoyal recommends a target temperature for water 
flowing to the pad within the range of 7.2-15.6°C (45-60°F) [29], with specific operating 
temperatures of 7.2±2.8°C (45±5°F) and 6.1-18.3°C (43-65°F) for models T505 and 
T600 [30], respectively. Game Ready [31] claims that the greatest benefit from 
cryotherapy takes place at 4.5-15.5°C (40-60°F). Bledsoe [32,33] states that their devices 
are designed for the temperature of water circulating within the pad to remain at or above 
4.4°C (40°F) with other specific recommendations for particular treatment sites, the 
highest being 10-15°C (50-59°F) for the ankle and the lowest 7-12C (44.6-53.6°F) for 
the back, knee and shoulder [33].  DonJoy warns against using their CTU with a water 
temperature lower than 5C (40F) [34]. Breg specifies different temperature ranges 
depending on the protocol. The temperature range of cooling water for continuous long 
term operation is 7.2C – 12.8C (45F - 55F), and the temperature may be below 7.2C 
(45F ) for intermittent exposures of 20 minutes or less [35]. EBIce only stipulates that a 
licensed health care practitioner must prescribe the appropriate treatment details [36] 
while warning that cooling pads may have wide temperature variation and that cold spots 
create the potential for tissue damage, and nerve palsy while hot spots may create areas of 
lessened therapeutic effectiveness. 
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1.4 MODES OF INJURY 
Localized cooling in non-glabrous skin results in on site vasoconstriction through 
different mechanisms such as activation of Rho-Rho kinase pathway in early stages of 
cold exposure and the inhibitions of nitric oxide system in its later stages [37–41]. 
Extended exposure to cold-induced vasoconstriction could lead to state of ischemia with 
tissue deprivation of oxygen and nutrients supply  required to sustain cell metabolism and 
accumulation of toxic byproducts that may cause injuries which typically fall within the 
domain termed nonfreezing cold injury (NFCI) manifested by necrosis and nerves 
damage [42–46]. In addition, a prolonged state of vasoconstriction can lead to the 
occurrence of reperfusion injury when blood flow is reestablished to the affected tissue 
[47]. 
Tissue ischemia is expected to play a major role in tissue necrosis caused by 
cryotherapy [46]. Nerve damage seems to be ischemia related although low temperatures 
also play a role. Localized cooling of nerves has been associated with the following 
changes in endoneurial and epineurial capillaries: increased blood viscosity, plasma 
skimming, cellular aggregation, damage to endothelial cells and resulted endoneurial and 
epineurial edema[47,48]. Additionally, some degree of constriction is reported in 
arterioles, and venules. Jia, et al. [47] also report a no reflow situation in these vessels 
where the flow does not reestablish in vessels after few hours of rewarming. There are 
also some reports of thrombotic events taking place. The hypoxia could be followed with 
a hyperemia phase when the flow returns and might be associated with reperfusion injury 
[44,48].  
Therefore, it is desirable to be able to characterize the mechanistic relationship 
between the application of therapeutic cooling to skin and the reduction of blood flow in 
affected tissue structures. 
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1.5 INJURY PREVENTION 
The primary mechanism of NFCI is based on ischemic driven events, one 
approach to avoiding that injury is to interrupt the ischemic state in a way that it still 
allows the benefits of cryotherapy to be realized. We have performed many experiments 
that evaluate various mechanisms to interrupt ischemia. The results of some of these 
studies which were deemed less desirable are reported in the appendix B. these studies 
indicate that brief intermittent episodes of rewarming the tissue presents the best 
approach to regulating ischemia. 
Localized heating can be used to increase blood perfusion in tissue in a three-
phase vasodilatory response. First, there is a transient increase in perfusion followed by a 
prolonged plateau response and a die away phase. The early, transient increase in 
perfusion seems to be caused by axonal reflex and is mainly mediated via warm receptors 
or heat-sensitive nociceptors. It is suggested that sympathetic function, though not 
required for the axonal reflex, poses a supporting role. Nitric oxide (NO) system is the 
main reason for the sustained vasodilation during the plateau phase. The endothelial NO 
(eNO) is reported to be responsible for 50% of heat-induced vasodilation during the 
plateau phase with no role in the early transient increase in perfusion. It is suggested that 
the vasodilatory effect of eNO might be more complex than the NO synthase (NOS) 
kinetics and other thermally sensitive enzymes which eNO is a substrate to might be 
involved. NO results in vasodilation through its sympathoinhibitory role as well as its 
direct effect on smooth muscle cells. The die-away phase is observed when the heating 
lasts for more than 60 min and it is indicated by a significant reduction in cutaneous 
vasodilation and is suggested to be under adrenergic control [38]. 
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Thermal blood flow stimulation as well as other possible methods to increase 
tissue perfusion as described in literature [49–51] were tested and are discussed in more 
details in Appendix B. 
1.6 RESEARCH MOTIVATION AND OUTLINE 
My analysis of the state of the art cryotherapy indicates that the control of blood 
flow by adjusting tissue temperature relating to both the therapeutic advantage of 
technology and to its potential for causing injury therefore for my PhD research I have 
undertaken a rigorous experimental analysis of the coupling of tissue blood flow to 
temperature. I have conducted an aggregate of 230 human subject experiments and based 
on this work to date, we have submitted 4 archival papers, one book chapter and five peer 
reviewed conference proceedings. 
In the work described here, I have attempted to expand upon the understanding of 
and to improve cryotherapy practices. Even though, cryotherapy is widely practiced in 
clinical fields and by athletic trainers many aspects of it remains anecdotal. The applied 
temperature and the duration of application vary widely between recommendations. The 
boundary condition applied at skin level is ignored and the understanding of skin 
temperature and vascular response to localized cooling needs improvement. In the 
following chapters I have endeavored to address some of these issues. Chapters 2-5 are 
free standing papers that are either accepted for publication or were just submitted. 
Chapter 6 presents additional research that I have accomplished but is not yet embodied 
in a manuscript that has already been submitted but it will be in the future. 
In Chapter 2 I have offered a phenomenological description of skin temperature 
and perfusion response to localized cooling. This chapter provides temperature and 
perfusion data from multiple cryotherapy experiments using CTUs. These experiments 
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are chosen from more than 100 cryotherapy experiments performed on 27 subjects. The 
length and applied temperature of the cooling portion of the experiments vary from 1 to 
80 min and 7 to 25ºC, respectively. I also touch on the concept of dose-dependent 
response of perfusion to duration of application. I demonstrate that increasing the 
duration of application further reduces tissue perfusion up to cooling duration of 30-40 
min beyond which no further reduction if perfusion is observed. 
I investigated the temperature profile on cooling pad using IR imaging in Chapter 
3. Total of 13 CTUs were investigated with 1-3 device-specific pad types/CTU. To 
analyze IR images, different statistical approaches were used to define temperature 
uniformity of pad surface including, min, max and temperature range. I also expressed 
the temperature range for the middle 90%, 86.5% and 63.2% of occupying the pad 
surface.  
Chapter 4 is based on a selection of 17 experiments using 4 CTUs. In this chapter 
I showed a significant reduction in tissue perfusion after 60 min of active cooling and that 
the result was not different between different device types or the two body parts under the 
study (knee and foot/ankle). I also demonstrated the persistence of vasoconstriction 
during the recovery period after cessation of active cooling using different statistical 
method such as a case-control study, pair-wise comparison and mixed model regression 
analysis. 
In chapter 5 I revisited the concept of persistence of vasoconstriction during the 
rewarming period. The data presented in this chapter was based on 6 cryotherapy 
experiments using a CTU. I showed that perfusion did not increase significantly for at 
least the first 90 min of the rewarming period using multiple statistical tests. 
Additionally, I introduced and discussed the hysteresis effect between skin temperature 
and perfusion during cooling and rewarming. I postulated that this hysteresis affect was 
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possibly due to release of a humoral agent that prevents vasodilation during the passive 
rewarming even though the skin temperature is returning to its original values. Another 
contributing factor could be the biophysical effect of cold that lasted beyond the cooling 
period. 
We have studied cryotherapy with more complete instrumentation and analysis 
that we believe has been done in the past. Our research has led to discovery of several 
physiological phenomena that have not been identified previously. These new insights 
have led to the design and development of improved devices and methods for performing 
cryotherapy more safely and effectively. 
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Chapter 2: Experimental Characterization of the Domains of Coupling 
and Uncoupling Between Surface Temperature and Skin Blood Flow1 
ABSTRACT 
Purpose: Local therapeutic cooling to soft tissue is known to sometimes cause 
necrosis and neuropathy via cold-induced ischemia. The purpose of this study is to 
quantify the occurrence and persistence of cold-induced ischemia associated with 
cryotherapy.  
Methods: FDA approved or exempt cryotherapy devices were applied for 
localized cooling on human subjects via recommended user protocols. Subjects were 
instrumented on the cooling site with thermocouples and laser Doppler blood flow 
probes.  
Results: Local cutaneous blood perfusion was depressed to as little as 15% to 
20% of baseline and remained depressed for hours following the cessation of active 
cooling. Induction of vasoconstriction was coupled to active surface cooling, and 
persistence of vasoconstriction was decoupled from subsequent passive surface 
rewarming.  
Conclusions: Skin blood flow drops progressively during active cooling of skin, 
but during subsequent passive rewarming the flow may remain deeply depressed and 
decoupled from the increasing skin temperature. There is a large hysteresis between skin 
temperature and blood flow during the tissue cooling and warming cycle, having 
important implications for therapeutic efficacy and safety. 
Keywords: bioheat transfer, cryotherapy, hysteresis, ischemia, skin blood 
perfusion, tissue cooling 
                                                 
1 This chapter is based on the manuscript accepted for publication by The International Journal of 
Transport Phenomena coauthored by Sepideh Khoshnevis, Natalie K. Craik and Dr. Kenneth R. Diller [52]. 
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INTRODUCTION 
Localized cooling is commonly used following orthopedic surgery and in sports 
medicine to reduce swelling, pain, inflammation, metabolism, muscle spasm, and 
bleeding [53,54]. Cryotherapy protocols are typically carried out in conjunction with post 
orthopedic surgical rehabilitation via a device called a cryotherapy unit (CTU). In 
contrast with acute cooling treatments used for sports injuries by application of a flexible 
bag of ice or a gel pack for a relatively short time, cryotherapy as an adjuvant to a 
surgical procedure is often maintained continuously for days up to a week [9,25,55] 
based on the extended operating capabilities of a CTU. Most CTUs consist of an 
insulated container that can be filled with an ice and water mixture and into which an 
immersion pump is placed to produce a circulation of ice water through a flexible 
polymeric bladder placed onto the treatment site over a thermal barrier. In general the 
quantitative insulating properties of the barrier are not specified or enforced integrally to 
the CTU with the result that a very wide range of temperatures may be created on the 
skin surface. Our studies show that the temperature of water flowing through the bladder 
may be as low as 2C, with the temperature on the bladder surface on the order of 5C 
and the skin surface ranging variously over the range from less than 10C to 25C or 
higher. For reference, the temperature of the skin surface when exposed to a 
thermoneutral environment generally falls within the range of 30C to 34C. The 
variation in temperatures over the surface of a bladder may be 10C or greater in the 
absence of a thermal load, with attendant larger thermal gradients on the skin in the 
treatment area.  
CTUs often have no thermal controller, or have one that is not based on a 
feedback signal from the skin temperature, although regulation of the skin surface 
temperature is the operational target for the therapeutic procedure. As a consequence, 
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there can be a large variation in the thermal performance of CTUs, some resulting in 
limited ability to regulate and execute thermal therapeutic procedures. In this context, a 
primary physiological response to the imposition of a reduced skin surface temperature is 
modulation of red blood cell flux through tissue in the treatment area. If one is to design a 
CTU to embody thermal operating characteristics to achieve a desired physiological 
outcome, it is necessary to have a quantitative description for the extent of the coupling 
behavior between skin blood flow and applied surface temperature. 
Although therapeutic cooling is tolerated by many patients, there are instances in 
which application of a CTU for an extended time has led to extensive tissue necrosis 
and/or nerve injury in the treatment area, sometimes with dire medical consequences 
[13,56–58]. These events are thought to be a result of the application of cold to the skin 
surface causing a major loss of blood perfusion in the underlying tissues, resulting in a 
state of ischemia (low blood flow) that deprives tissue of the supply of oxygen and 
nutrients required to sustain cell metabolism [45]. Further, the diminution of blood 
perfusion will allow an accumulation of toxic metabolic byproducts that would normally 
be carried away from tissues by blood. The consequence is a state in the tissue conducive 
to the occurrence of nonfreezing cold injury (NFCI) that may be manifested in the death 
of cells (necrosis) and nerves (neuropathy) [43]. Therefore, it is desirable to be able to 
characterize the mechanistic relationship between the application of therapeutic cooling 
to skin and the reduction of blood flow in affected tissue structures.  
To this end, we have conducted more than 200 human tests on many different 
commercially marketed CTUs on four specific areas of the body while measuring the 
transient temperature and blood perfusion responses of the skin. The protocols embodied 
an initial period of benchmark data with the bladder applied but no water flow, followed 
by active cooling with the CTU pumping cold water through the bladder, and finally a 
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period of passive rewarming with the water flow terminated, but the bladder still 
remaining in place at the treatment site. The protocols were approved by the University 
of Texas Institutional Review Board (IRB) and were designed and implemented to mimic 
typical prescribed uses of the devices. 
METHODS 
Data presented in this paper is based on experiments run on FDA approved or 
exempt, commercially available cryotherapy devices, including: Breg Polar Care 300, 
500, and 500 Lite (Breg, Carlsbad, CA), DeRoyal T505 and T600 (DeRoyal Industries, 
Powell, TN), Game Ready (Game Ready, Concord, CA), Artic Ice System (Pain 
Management Technologies, Akron, OH), and DonJoy Ice man 1100 and Aircast 
Cryo/Cuff (DonJoy Global, Vista, CA). The data reported herein were recorded for 
cooling at one of the following sites: the knee, the shoulder, the ankle, or the straight 
length of the lower leg between the knee and the ankle (calf and shin area). 
Blood perfusion was measured using Moor VMS-LDF2 and VMS-LDF1-HP laser 
Doppler flow probes (Moor Instruments, Millwey, Axminster, Devon, UK), thin ribbon 
and small bead thermocouples (Omega Engineering, Stamford, CT), and a heat flux 
gauge (Omega Engineering, Stamford, CT), all mounted directly onto the skin at the site 
of active cooling. The laser Doppler probes have different focal depths of sensing blood 
flow, the LDF2 at about 0.5mm and the LDF1-HP at about 2mm [59]. These are denoted 
as superficial and deep measurements, respectively. The superficial probes incorporate a 
thermistor on the surface of the fiber optic window to monitor the local skin temperature. 
Blood pressure was monitored intermittently on the upper arm with a 
sphygmomanometer, and the values were applied to normalize the blood perfusion 
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measurements to calculate the cutaneous vascular conductance (CVC), where the CVC is 
defined in arbitrary units as: 
CVC = laser Doppler flux /mean arterial pressure. 
National Instruments data acquisition modules NI 9201, 9205, 9211, and 9213 
and NI DAQ chassis 9172 and 9174 (National Instruments, Austin, TX) were used to 
collect blood perfusion and temperature data and as an interface for computer logging, 
respectively. Temperatures were measured with a tolerance of ±0.5°C. All data was 
collected with a sampling rate of 12 HZ, and temperature data was subsequently down 
sampled to 4 Hz.  
The area on the skin to which the cooling bladder was applied was covered with a 
thermal insulation barrier consisting of either a single loose layer of elastic bandage 
(ACE) or a therapeutic stocking (TED). The barrier also covered all thermal 
instrumentation placed directly onto the skin under the bladder, but only surrounded the 
laser Doppler probes because they have a sensor elevation of about 1 cm above the skin 
surface. A thermocouple was also placed on the surface of the cooling bladder directly 
overlaying one of the skin temperature measurement thermocouples. In some instances 
tee connectors with a thermocouple positioned in the side branch were inserted into inlet 
and outlet water lines adjacent to the bladder to monitor the water temperatures at those 
points. 
The subjects were either seated with their back at a 45º angle from horizontal and 
the legs extended on the same plane as the hips or reclining in a supine position for the 
duration of each experiment. Physical movements of the limb being tested were kept to a 
minimum to avoid introducing blood flow measurement artifacts. All experiments were 
performed at a constant ambient temperature and relative humidity of approximately 
23C and 50%. A light blanket was placed over the subject, at his/her request, to diminish 
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any vasoactive response driven by whole body thermoregulation inputs, especially to 
avoid any reaction to a possible general cooling of the overall skin surface that might 
induce vasoconstriction. 
The sequence by which instrumentation and a cooling bladder were applied to a 
subject at a test site is illustrated in Figure 2.1. 
 
 
Figure 2.1.  Instrumentation of a subject for a CTU tested on the right knee. The view is 
from the ventral aspect. (a) Sensors applied to the skin, including six smaller rectangular 
thermocouples, one larger square heat flux gauge, and three fiber optic probes for laser 
Doppler measurements. Numbers written on mounting tape indicate connection junctions 
of lead wires to the DAQ. (b) The same area after a thermal insulation barrier consisting 
of a single layer of ACE bandage wrap has been applied with no elastic stretching. (c) A 
Breg Polar Care cooling bladder positioned over the thermal barrier. 
Approximately one hour was required to apply and connect all of the 
instrumentation onto the subject at the beginning of an experimental session and to 
confirm its function. This process allowed the subject to become acclimated to the 
experimental environment. Extant room temperature water remained captured within the 
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bladder until the cooling process was commenced by the circulation of ice water. After 
all of the instrumentation was in place and its function verified and a layer of insulating 
material was applied to the testing area, the cooling bladder was placed onto the 
treatment site, after which the bladder surface temperature rapidly approached that of the 
skin. Each protocol was initiated with a 10 to 45 minute period of baseline data 
acquisition before ice water flow into the bladder was initiated. The purpose of this 
period was to obtain values for perfusion and temperature to which subsequent changes 
elicited by the cryotherapy procedure could be normalized. Although the values of 
temperature and especially of blood perfusion were never perfectly static, baseline 
variations were small in comparison with those caused by the cooling procedures. 
The cooling process was initiated at the end of baseline data collection by turning 
on the CTU pump to produce a steady flow of ice water through the bladder (or by 
increasing the elevation of the ice water container for gravity feed devices.) The duration 
of the cooling period was a primary control parameter evaluated in this study. Ice water 
flow through the bladder was maintained continuously for a wide range of times, 
including approximately 1, 2, 3, 5, 10, 30, 40, 60, and 80 minutes, as well as others, and 
in some trials the protocol was repeated one or more times. 
The cooling process was terminated by turning off the ice water pump, following 
which both the bladder and the underlying tissues began to warm via a combination of 
parasitic heat gain from the environment and active warming from within the tissues by 
metabolism and convection of blood. Both of the latter physiological effects were 
depressed at the lower local tissue temperatures. The period of time over which the 
rewarming process was monitored also was varied for a wide range of values from 30 to 
240 minutes. In some trials cooling was reinitiated following a defined period of 
rewarming to establish a cooling and rewarming cycle that could be reiterated. Table 2.1 
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presents a summary of the value ranges that were measured for key parameters for the 
aggregate of the CTU trials conducted. 
 
Parameter 
Measured Range 
Units 
Minimum maximum 
Baseline period 15 39 min 
Cooling temperature 7 25 C 
Cooling period 1 80 min 
Warming period 30 240 min 
Maximum drop in perfusion from baseline -31 -85 % change 
Table 2.1. Summary of measured ranges of temperatures, cooling rates, cooling duration, 
and blood flow depression for the CTUs tested. 
RESULTS 
The reported experiments were conducted on healthy adult subjects covering the 
age range of 20 – 70 years. In total more than 110 CTU trials have been conducted on 27 
subjects, approximately evenly divided between males and females. The selected results 
reported herein are representative of and consistent with the physiological response to the 
application of cryotherapy observed and measured in all trials. They are chosen to 
illustrate the phenomenological domains of coupling between skin temperature and skin 
blood perfusion encountered during CTU protocols, including active cooling and passive 
rewarming.  
The data are presented primarily in terms of plots of the concurrent time variation 
in temperature and blood perfusion at specific sites under the cooling bladder. For trials 
lasting as long as six hours and involving data acquired in parallel from 10 or more 
sensors, the amount of information generated is large. Only certain transducer outputs are 
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displayed for each experiment so as to not obscure individual sensor behaviors by 
crowding and overlapping of plot lines.  As would be anticipated, data are not replicated 
exactly among the various trials or even among various sensor locations for an individual 
trial, but a number of very important consistent behaviors have been identified. The 
results are presented in a format to emphasize the primary and most significant 
phenomena that have been measured and characterized. Perfusion data plots are the result 
of time averaging over a 3 minute moving window unless otherwise specified. The data 
from individual CTU trials follow. 
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Figure 2.2. Data for a cryotherapy trial with a DonJoy Iceman 1100 system applied to the 
calf and shin consisting of 30 minutes of baseline data, followed by active cooling for 60 
minutes and passive rewarming for 150 minutes. (a) Temperature histories measured at 
two locations on the skin under the water perfusion bladder (red and green) and on the 
surface of the bladder (cyan). (b) P1 and P2 represent perfusion histories under the 
cooling bladder. 
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Figure 2.3. Data for a cryotherapy trial with a Breg Polar Care 500 Lite system applied to 
the knee consisting of 30 minutes of baseline data, followed by active cooling for 10 
minutes, and passive rewarming for 180 minutes, resumption of active cooling for 5 
minutes, and passive rewarming for 20 minutes. Double arrows mark the duration of each 
cooling cycle. (a) Temperature histories measured at two locations on the skin under the 
water perfusion bladder (red and green) and on the surface of the bladder (blue). (b) Two 
superficial (magenta and green) and one deep (red) perfusion histories under the cooling 
bladder.  
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Figure 2.4. Data for a cryotherapy trial with a DeRoyal T600 applied to the shoulder 
consisting of 15 minutes of baseline data, followed by active cooling for 80 minutes, and 
passive rewarming for 30 minutes. (a) Temperature histories measured at two locations 
on the skin under the water perfusion bladder (red and green) and on the surface of the 
bladder (blue). (b) Two superficial (magenta and green) and one deep (red) perfusion 
histories under the cooling bladder.  
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Figure 2.5.  Data for a cryotherapy trial with an Arctic Ice System applied to the calf and 
shin area of the lower leg, consisting of 15 minutes of baseline data, followed by active 
cooling for 40 minutes and passive rewarming for 90 minutes. (a) Temperature histories 
measured at two locations on the skin surface under the cooling bladder (black and blue). 
(b) Superficial (green and magenta) and deep (red) perfusion histories at three sites in the 
skin under the cooling bladder. Perfusion data was time averaged over a 1 minute moving 
window as distinguished from a 3 minute window for the other trials. 
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Figure 2.6. Data for a cryotherapy trial with an Arctic Ice System applied to the calf and 
shin area of the lower leg, consisting of 30 minutes of baseline data, followed by active 
cooling for 1 minute and passive rewarming for 195 minutes. (a) Temperature histories 
measured at two locations on the skin surface under the cooling bladder (red and green) 
and on the surface of the bladder (blue). (b) Superficial (green and magenta) and deep 
(red) perfusion histories at three sites in the skin under the cooling bladder. 
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Figure 2.7.  Data for a cryotherapy trial with an Arctic Ice System applied to the calf area 
of the lower leg, consisting of 39 minutes of baseline data, followed in sequence by 
active cooling for 1 minute and passive rewarming for 37 minutes, 2 minutes of active 
cooling and 96 minutes of passive rewarming, and 3 minutes of active cooling and 122 
minutes of passive rewarming. (a) Temperature histories measured at two locations on 
the skin surface under the cooling bladder (red and black) and on the surface of the 
bladder (blue). (b) Superficial (green and magenta) and deep (red) perfusion histories at 
three sites in the skin under the cooling bladder.  
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Figure 2.8. Data for a trial with a Game Ready CTU applied to the knee, consisting of 10 
minutes of baseline data, followed sequentially by active cooling for 30 minutes and 
passive rewarming for 30 minutes, then a second identical episode of active cooling for 
30 minutes and passive rewarming for 30 minutes. (a) Temperature histories measured at 
two locations on the skin surface under the cooling bladder (red and green) and on the 
surface of the bladder (blue). (b) Superficial (green and black) and deep (red) perfusion 
histories at three sites in the skin under the cooling bladder. The blue plot shows the 
temperature history measured via one laser Doppler probe. Note that the intermittent 
pressurization feature was operative during this trial in which an outer air bladder was 
periodically inflated and deflated for 90 seconds sequentially. 
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Figure 2.9. Data for a trial with an Aircast Cryo/Cuff CTU applied to the knee, consisting of 26 
minutes of baseline data, followed which the cooling bladder was filled with ice water by gravity 
feed with the source container elevated approximately 0.3 m above the bladder and kept in 
position with the air vent opened for approximately 56 minutes. The source container was then 
lowered below the bladder to allow the water to drain from the bladder, and at 60 elapsed minutes 
after the first cooling episode it was again raised 0.3 m above the bladder to provide a second 
cooling cycle. A third cooling episode was initiated after an additional 72 elapsed minutes. A 
slight perturbation to the slope of the temperature plots can be observed during the lowering of 
the source container just prior to the start of subsequent cooling episodes. (a) Temperature 
histories measured at two locations on the skin surface under the cooling bladder (red and black) 
and on the surface of the bladder (blue). (b) Superficial (green and magenta) and deep (red) 
perfusion histories at three sites in the skin under the cooling bladder. The black plot shows the 
temperature histories measured via the thermistor on one of the two low power laser Doppler 
probes. Black arrows point to the start of each cooling period. 
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Figure 2.10. Data for a trial with a Breg Polar Care 300 cryotherapy unit applied to the 
knee, consisting of 30 minutes of baseline data, followed by active cooling for 60 minutes 
and passive rewarming for 84 minutes. (a) Temperature histories measured at two 
locations on the skin surface under the cooling bladder (red and green) and on the surface 
of the bladder (blue). (b) Superficial (green and magenta) perfusion histories at two sites 
in the skin under the cooling bladder.  
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Figure 2.11. Data for a trial with a DonJoy Iceman 1100 unit applied to the ankle, including 34 
minutes of baseline data, followed by active cooling for 60 minutes and passive rewarming for 86 
minutes. Temperature histories were measured at two locations on the skin surface under the 
cooling bladder (red and green) and on the surface of the bladder (blue). (b) Skin blood perfusion 
measured at two locations under the cooling bladder. The magenta perfusion plot shows a sudden 
increase and decrease with the initiation and termination of water flow through the cooling 
bladder, respectively, due to sudden change in applied mechanical pressure. This effect is not 
seen in the green perfusion plot. This variation in response is likely due to differences in the 
anatomical locations of the probes relative to the water flow pattern within the bladder and 
alteration of the probe/tissue orientation with the start and stop of pressurized water flow through 
the bladder. Double arrows mark the duration of cooling which lasted for 60 minutes.  
30 
 
 
 
Figure 2.12.  A control experiment with full instrumentation and a Breg Polar Care 500 Lite 
cooling bladder applied to the knee. Thermally neutral skin temperature water at about 32C was 
pumped through the bladder from 125 to 155 minutes. There was no water flow through the 
bladder at other times. (a) Temperature histories measured at two sites on the skin under the 
cooling bladder (red and green) and on the surface of the bladder (blue). (b) Skin blood perfusion 
measured in the skin at two locations under the cooling bladder. P1 (green) and P2 (red) represent 
superficial and deep perfusion measurements, respectively. Also, the temperature measured via 
the thermistor on the laser Doppler probe at the superficial perfusion site is plotted (blue). 
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The foregoing figures illustrate the existence of a profound and persistent state of 
ischemia following the cessation of active cooling when the cooling bladder and 
underlying tissues are allowed to passively rewarm via natural convection with ambient 
air. This general behavior has been observed for the entire spectrum of standard 
cryotherapy protocols we have investigated. In this context, we undertook a nonstandard 
protocol in which an active rewarming process was imposed following a period of usual 
passive rewarming by circulating heated water through the cooling bladder. The prime 
objective of this study was to see if active heating could be used to break the state of 
post-cooling ischemia. Following active rewarming, a second cycle of active cooling and 
passive rewarming was applied to determine whether the state of persistent post cooling 
ischemia would be reestablished. The transient temperature and perfusion plots for this 
study are shown in Figure 2.13. 
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Figure 2.13.  Data for a trial with a Breg Polar Care 500 cryotherapy unit applied to the knee, 
consisting of 30 minutes of baseline data, followed by active cooling for 40 minutes and passive 
rewarming for 90 minutes, then active rewarming for 27 minutes, passive heat transfer for 22 
minutes, then active cooling for 42 minutes and passive rewarming for 40 minutes. (a) 
Temperature histories measured at two locations on the skin surface under the cooling bladder 
(red and black), on the surface of the bladder (blue), and in the water flow lines at the bladder 
inlet (cyan) and outlet (green). (b) Superficial (green and magenta) perfusion histories at two sites 
in the skin under the cooling bladder. Output from a heat flux gauge on the skin (red). The 
temperatures measured via the thermistors on both laser Doppler probes are plotted to show the 
correlation between perfusion and temperature.  
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Inspection of the thermal data presented in the foregoing figures shows that there 
is variation in the temperatures measured at different skin sites under a cooling bladder 
during individual trials. One possible source of these variations may be due to thermal 
gradients on the surface of the cooling bladder. Therefore, we acquired thermal images of 
the surface of a cooling bladder through which water was circulating to quantify the 
spatial disparities in the temperature pattern. For this purpose we placed a bladder in an 
unfolded configuration onto a flat surface with the cooling surface oriented upwards. We 
positioned a thermal camera (FLIR Systems, Boston, MA) directly above the bladder to 
record the two dimensional pattern of temperature on the surface. An example image for 
a Breg Polar Care 300 knee pad is shown in Figure 2.14. A more comprehensive analysis 
of this phenomenon will be reported in another companion paper. 
 
 
Figure 2.14.  Infrared thermograph of the temperature distribution on the surface of a 
Breg Polar Care 300 knee bladder during perfusion with ice water. The surface was 
exposed to room air at 23C. 
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There was no water condensation on the bladder surface that could corrupt the IR 
image. Temperatures are indicated on a pseudocolor scale. An exemplar flow pathway 
was manually traced between the inlet and outlet as indicated by the red line, with the 
temperatures of individual image pixels along the path plotted to the upper right. The 
warming differential on the bladder surface between inlet and outlet is about 4.5C. Areas 
near the periphery of the water flow path and where the upper and lower surfaces of the 
bladder are welded together are substantially warmer. Temperature differences over the 
bladder surface are as large as 8C. 
A striking feature that is common to all of the CTU experiments we have 
conducted is that there is a profound hysteresis effect between the temperature applied 
during cryotherapy and the responsive skin blood flow as illustrated by the two exemplar 
data sets in Figure 2.15. During cooling the skin blood flow follows the falling skin 
temperature to values that are a small fraction of the precooling baseline value. When the 
skin temperature rises after cessation of active ice water flow, the rate of blood flow 
remains nearly static, in the absence of external stimulation, for periods that can extend 
for hours. The direct coupling, or lack thereof, between skin perfusion and temperature 
are illustrated by the hysteresis loop that develops through a cooling and heating cycle 
and is a primary feature of the physiological response to cryotherapy.  
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Figure 2.15.  Hysteresis in local skin blood flow responding to falling and rising skin 
temperatures during cryotherapy for two different devices and subjects. Owing to 
experimental time limitations the cryotherapy cooling and heating cycle did not 
accommodate a complete return of perfusion to its baseline value. 
DISCUSSION 
The data plots, as an aggregate, document temperature and blood perfusion 
characteristics that are common across all of the trials we have conducted with various 
devices on different areas of the body and that provide broad insights into the 
physiological response to cryotherapy. Perhaps the most significant outcome of this study 
is that the application of a CTU procedure initiates a state of persistent ischemia at the 
treatment site. In the absence of an independent stimulation of blood flow, the ischemic 
state may extend long after the circulation of ice water is terminated. The impact of this 
outcome is the fact that exposure to ischemia over an extended period of time may 
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contribute to the development of tissue necrosis and neuropathy, as has been recognized 
widely in prior literature. There are also differences among the measured temperatures 
and blood perfusions among and within the various trials that are important to recognize 
and understand. These are discussed as follows. 
Temperature Effects 
As would be anticipated, during cooling the temperature on the bladder surface 
drops ahead of the skin temperature, creating a gradient in which heat flows from tissue 
to the bladder and the cold water circulating through it. For trials in which active cooling 
lasted long enough for the bladder surface temperature to reach a steady state value (Figs 
2.4(a), 2.10(a), 2.11(a), 2.13(a)), the skin continued to cool long after the bladder was at 
steady state. This behavior is due in large part to the much larger thermal mass of the 
tissue being cooled in comparison with the bladder and to the fact that the bladder is 
located more proximally to the heat sink provided by the circulating ice water. In like 
manner, in Figure 2.13(a) the temperature of the water circulating in the bladder precedes 
the bladder surface temperature in decreasing during cooling starting at 30 and 210 
minutes and in increasing during warming starting at 160 minutes. The difference 
between the inlet and outlet temperatures is less than 1C. This temperature difference, 
multiplied by the specific heat of water and the mass flow rate through the bladder, can 
provide an indication of the rate of heat transfer between the bladder and the skin. 
Another feature of the temperature data is that the rates of temperature drop 
during active cooling with forced convection are always much larger than the rates of 
temperature rise during passive rewarming via natural convection. The differential in heat 
transfer rates during active and passive rewarming processes is illustrated dramatically in 
Figure 2.13(a) in which the slopes of the tissue temperature curves increased abruptly 
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when warm water was perfused through the cryotherapy bladder. At 187 minutes when 
the water perfusion through the bladder was ceased, converting the environment for the 
skin from forced to free convection, albeit with the same water temperature in the 
bladder, there is an immediate change from an increasing to a decreasing slope of the 
transient temperature gradient. This inversion of the slopes of the skin temperature curves 
illustrates clearly the strong effect imposed on the underlying tissue by switching from a 
forced to a free convection boundary condition. Operation of the bladder with a forced 
convection flow of water is an important component of the functionality of cryotherapy 
units. Another example of this phenomenon is seen by comparing the cooling curves for 
the Aircast Cryo/Cuff device in Figure 2.9(a) with those of the forced convection devices 
in all other cryotherapy trial figures. The Cryo/Cuff device operates via a single 
admission of ice water into the bladder where it remains static for the duration of the 
cooling cycle in the absence of a forced convection source that is able to sustain a 
continuous high rate of heat removal from the tissue. Therefore, following an initial drop 
in temperature on the surface of the bladder, there is a continuous rise in temperature as 
the bladder absorbs heat from the underlying tissue. The rate of heat transfer decreases 
continuously as the temperature differential between the bladder and the skin diminishes.  
In all of the trials the temperatures of the skin and the bladder were rising during 
the initial baseline period during which there is no active temperature control imposed. 
This trend occurs because metabolism and blood flow in the tissue provide an inner 
source of heat, and the outer bladder layer provides insulation of underlying structures. 
The result is that energy is generated and transported within the tissue at a rate larger than 
it can be lost via passive heat transfer to the environment, resulting in a net accumulation 
of energy that drives the temperatures upward prior to starting the circulation of ice water 
through the bladder. 
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The data in all of the trials also show that there were always positional differences 
in temperature histories. For example, there may be points on the skin surface with 
temperatures as low as 8 – 9C, whereas on occasions during a single trial there may be 
other locations that simultaneously are 20C or higher. For clarity in viewing and 
interpreting the temperature data we have presented plots for only a minimal number of 
measurement sites, but much more data was gathered that supports this behavior. There 
are multiple potential contributing causes for spatial variations in temperature. (i) There 
may be differences in the local thicknesses of the thermal barrier. Typically a thermal 
barrier is placed between the bladder surface and the skin, although in general the device 
manufacturers do not define or specify specific standards for the thermal properties of 
barriers to be applied by end users. This effect is most probable when the barrier is 
applied as a wrap that may have a nonuniform pattern of application causing uneven 
thermal resistance. (ii) The temperature distribution on the surface of the cooling bladder 
is known to have spatial variations, as shown in Figure 2.14. These variations will 
translate to gradients on the skin surface. (iii) The bladder may not fit uniformly against 
the thermal barrier and the underlying tissue, resulting in creation of insulating air gaps 
that will act as a thermal contact resistance, depending on the relative geometries of the 
bladder and the anatomy, causing a larger temperature drop between the skin and bladder. 
This effect is difficult to quantify and predict, but it is very real. We have observed at 
sites of poor fit a skin to bladder temperature differential that can be 15 – 20C larger 
than at locations where there is an intimate fit. The local physiological response will be 
modulated if the conformation of the cooling bladder to the body surface is poor. (iv) 
There may be areas of higher contact pressure between the bladder and the thermal 
barrier and underlying tissue. Greater pressure will reduce contact thermal resistance and 
may also compress the barrier material, lowering its resistance. The thermal effect of 
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increased applied pressure on reducing the heat flow resistance is seen clearly in Figure 
2.8(a) for operation of the Game Ready device with cyclic pressure applied to the 
pneumatic cuff. Increased pressure reduces the temperature drop between the bladder and 
skin surface. Increased mechanical or pneumatic pressure will also further depress blood 
flow through the tissue, rendering it more susceptible to being cooled. 
The cryotherapy trials all involve the circulation of water from an ice bath 
through a bladder placed on the subject at a simulated treatment site. The water flow 
tubes are all insulated with a light foam material to minimize heat gain from the 
surrounding air. Some cryotherapy systems offer a control of the water temperature as it 
is supplied to the cooling bladder.  For systems in which ice water is pumped directly to 
the bladder, in line measurements of water temperature as it enters the bladder show 
values as low as 0.5C. As steady operating conditions are approached, the temperature 
of the outer cooling surface of the bladder may be as low as 3 – 6C, depending on the 
thermal resistance of the bladder material and the effectiveness of convection heat 
transfer with the water as it flows through the bladder.  
The therapeutic (and possibly injurious) response elicited in tissue occurs as a 
function of the applied temperature and duration on the skin surface. Thus, variations in 
the temperature pattern imposed onto the surface of tissue may compromise the execution 
of cryotherapy, resulting in an unintended or unwanted response. Accurately producing a 
targeted temperature field onto a treatment area remains a fundamental challenge in 
perfecting cryotherapy devices. 
Blood Perfusion Effects 
As noted earlier, we have now conducted more than 200 instrumented 
cryotherapy trials, all on healthy adult subjects, and every trial demonstrated a sharp 
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decrease in blood flow to the affected area that persisted subsequent to cooling unless 
there was an intervention to restimulate the flow. In the absence of instrumentation to 
monitor blood perfusion, as is commonly the case for the clinical use of cryotherapy 
devices, this phenomenon is not likely to be detected or to be perceived. Nonetheless, the 
affected tissue area will be deprived of a normal supply of oxygenated blood with 
nutrients, and toxic metabolic byproducts will accumulate locally. The result is a 
condition that can lead to cell injury and death which, if enabled to accrue on a large 
scale, may be manifested as clinically observed necrosis and/or neuropathy, with the 
more general descriptor of nonfreezing cold injury [46]. As noted in the background 
section, the literature of cryotherapy has many citations of these types of outcomes.  
There are a number of specific features of the blood perfusion response to 
cryotherapy in addition to persistent ischemia that should be highlighted. It is readily 
apparent that the blood perfusion curves are not as smooth as are the temperature curves, 
which is due to the difference in the nature of the control mechanisms. Regulation of the 
human cardiovascular system has been studied and written about extensively for many 
years. One of the more comprehensive and elegant reviews is found in the book of 
Rowell [60] to which readers are referred for details. As Rowell notes, “The primary 
function of the cardiovascular system is to deliver oxygen and nutrients to the tissues and 
to remove their waste products….Other important functions of the peripheral circulation 
are the regulation of blood pressure, body temperature, and distribution of blood volume, 
and the performance of the heart.” Simply stated, humans may experience variations in 
local blood flow in conjunction with changes in the driving pressure from the pumping 
heart and in the continuous redistribution of blood volume around the body via exquisite 
adjustments in vasomotor function that cause modulations in the local flow resistance. 
The latter factor is undoubtedly the primary source of the relatively rapid small scale 
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fluctuations in local blood flow rates observed in all of the data reported herein. These 
fluctuations occur in the normal functioning of the cardiovascular system and are not a 
consequence of the application of cryotherapy, as evidenced by data acquired during the 
baseline periods.  
The laser Doppler flow measurements may be subject to artifact generation owing 
to changes in the relative geometry between the probe and the skin surface. Such changes 
can occur if the subject moves or even flexes a muscle in the measurement area. 
Therefore, the subjects were cognizant to remain passively still throughout experimental 
trials to the greatest extent possible. Another source of movement artifact is the 
application or removal of a force that presses the probe normally or obliquely against the 
skin surface, as may occur when a CTU pump establishes or discontinues the flow of ice 
water through a cooling bladder that covers a probe. This effect can be observed in some, 
but not all, of the blood flow plots in conjunction with the start and end of the ice water 
pumping that defines active cooling periods. The control study of Figure 2.12 
demonstrates the pressure induced perturbation in flow measurement in the absence of a 
thermal influence on blood perfusion. A similar effect is observed in the data presented in 
Figure 2.11(b). In this experiment, two blood perfusion probes were applied to the skin 
under the cooling bladder. There are sudden changes in flow measurements with the start 
and stop of water flow in P2 (magenta line), whereas P1 (green line) only experiences a 
transient increase in flow with the start of the cooling and without any similar response 
with the stop of the water flow. As long as water flow was maintained through the 
cooling bladder, there was a constant upward offset in the value for P2 that disappeared 
when the flow stopped. The magnitude of the offset was approximately equal at the 
beginning and the end of the flow period. The difference in response between the two 
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probes is likely due to their relative positioning with respect to the bladder that could 
influence the degree of pressure loading they experienced during the flow of water.  
A pressure effect on blood perfusion measurements is also quite apparent in 
Figure 2.8(b) for operation of the Game Ready cryotherapy unit with its external 
pneumatic pressurization cuff activated periodically during cooling. Three probes were 
positioned on the skin beneath the cooling bladder during this trial, one deep and two 
superficial. Although all three probes had flow measurements altered by the application 
and release of pressure, there are marked differences among the magnitudes of these 
responses. These differences may be attributed to unique aspects of the relative 
positioning of the probes on the skin and under the bladder, causing differential 
sensitivities to the application of flow pressure within the bladder. In general, the 
application of pressure produces a reduction in measured blood flow in the underlying 
tissue, and release of pressure likewise produces an increase in flow.  
Another feature of the response of blood perfusion to the application of 
cryotherapy is the relative rate at which the local flow drops as the temperature is initially 
reduced. At the risk of oversimplification, the rates of perfusion drop can be grouped into 
two general classes: relatively slow and relatively rapid. Slow rates of decrease are seen 
in Figures 2.2(b) and 2.4(b), whereas rapid rates are seen in Figures 2.3(b), 2.5(b), 2.6(b), 
2.7(b), 2.10(b) and 2.13(b). Interestingly, Figures 2.8(b) and 2.9(b) show both slow and 
rapid rates of drop in blood perfusion among the different probes on the same subject 
during the same trial. These individual probes are located at different sites where there 
may be differentials in the applied thermal histories and in the local control of vasomotor 
regulation.  
A major question concerning the cryotherapy induction of ischemia is whether 
there is a dose response effect, where the dose is characterized in terms of both time and 
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temperature of exposure on the skin surface. As with most elicited biological responses to 
thermal stress, the application time and temperature during cryotherapy are not 
independent in their causative potentials for producing kinetic physiological reactions 
[61,62]. A full answer to this question would require a broad matrix of experimental 
studies that are beyond the scope of the current investigation, although we are currently 
engaged in experimental evaluation of the combined time and temperature dosage in 
causing vasoconstriction. Johnson [37,38,63,64], Thompson [41,65] and others [66] have 
studied in depth the effect of local cooling on cutaneous vasoconstriction, showing that 
temperature reductions to the range of 24C consistently can produce major 
vasoconstrictive responses to decrease cutaneous vascular conductance by as much as 
80% of baseline values. It is thought that inhibition of the NO vasodilator system may 
play an important role in this behavior [37,38]. Preliminary experiments by our research 
team using the microdialysis technique [67,68] are confirming to this mechanism for the 
cryotherapy induced vasoconstriction that persists following the completion of the active 
cooling portion of a protocol.  
The control data in Figure 2.12 for perfusion with water at a baseline skin 
temperature of 32C show no indication of a thermally induced vasoconstriction. During 
the last approximate 90 minutes of this trial the thermal insulating effect of the bladder 
and thermal barrier caused skin temperatures to rise continuously with a concomitant 
increase in blood flow to 50% above the baseline value. This effect is in accordance with 
data in the literature for the effect of heating skin on inducing vasodilation [38,69,70].  
Figure 2.13(b) presents the response of blood flow to active local heating via 
passage of warm water through the bladder that was started during the period of post 
cooling vasoconstriction. There was an immediate and continuous increase in the rate of 
skin blood flow throughout the time of active heating, resulting in blood perfusion values 
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that at one measurement site were well in excess of baseline. When the active heating 
was stopped, the blood perfusions leveled off at their peak values and were maintained 
until active cooling was resumed, at which time the cycle of deep vasoconstriction was 
again initiated, continuing into the post cooling period as occurred during the initial 
cycle. An interpretation of this data is that induction of a large positive heat flux into the 
skin offsets the action of the factor(s) that cause persistent vasoconstriction during and 
following active cryotherapy cooling, and that these factors are reestablished with 
subsequent cryotherapy application.  
We studied cryotherapy protocols in which the initial period of applied cooling 
lasted over a range of times from 1 minute (Figures 2.6(a) and 2.7(a)) to 80 minutes 
(Figure 2.4(a)) to determine the exposure time effect on the dose response of blood 
perfusion to cryotherapy. It is well understood from the principles of heat transfer that 
during the surface cooling of a semi-infinite medium such as the skin and underlying 
tissues, the cold front will penetrate inwardly as a wave [71]. Thus, the surface 
temperature will reduce progressively over time, and the extent of cumulative surface 
cooling will be much less for short periods of exposure than for longer periods. This 
effect is illustrated in Figure 2.16 which plots the minimum skin temperature reached 
during the initial cooling period as a function of the duration of exposure to a cooling 
bladder with continuously circulating ice water.  
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Figure 2.16.  Scatter plot of minimum temperature achieved on the skin surface as a 
function of the duration of the initial episode of cooling applied with a cryotherapy 
cooling bladder with continuously circulating ice water. Cumulative data from multiple 
trials previously reported individually. 
The data in Figure 2.16 are from Figures 2.2-2.8, 2.10-2.11 and 2.13, excluding 
Figure 2.9 which is for the Cryo/Cuff that does not provide a continuous circulation of ice 
water through the bladder and therefore produces a very different type of thermal 
boundary condition for the cooling process. Although this data is from four different 
device manufactures with their own cooling bladders and applied to three different areas 
of the body, there is clearly a common behavior to be observed. The surface temperatures 
reached after 30 minutes of cooling tend to fall into a group with a range of about 10  
4C, although the skin temperatures were continuing to fall asymptotically after even 60 
and 80 minutes of cooling. For shorter cooling periods, the drop in temperature was 
directly proportional to the duration of applied cooling (Figure 2.16). Importantly, for 
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even 1 minute of active cooling, the skin surface reached 24C, which corresponds to the 
value used by physiologists to study the effect of local cooling in causing 
vasoconstriction [37,38,63,64,66]. The effect of cryotherapy that carries the greatest 
potential impact on the risk of causing injury is the depression of blood flow. Figure 2.17 
presents aggregate data of the percentage depression of skin blood perfusion for all of the 
continuous flow cryotherapy trials (excluding the Cryo/Cuff). 
 
 
Figure 2.17.  Decrease in cutaneous blood perfusion as a function of the period of 
application of continuous flow ice water cryotherapy. Average and standard deviation 
values are based on data from each individual perfusion measurement from all trials. n 
varies between 2 and 6 as can be observed from Figures 2.2-2.8, 2.10-2.11, and 2.12. 
The data shows that even very brief periods of cryotherapy are sufficient to lower 
the skin to a temperature wherein significant vasoconstriction occurs. Figure 2.6(b) 
shows that for only 1 minute of cooling there can be a 25% to 50% depression of the 
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local blood flow that lasts for more than three hours, at which point in time this particular 
experiment was terminated. Figure 2.7(b) shows sequential cooling periods of 1, 2, and 3 
minutes for which there is an accumulative temperature effect that precipitates a 
compounded long term diminution in the cutaneous blood flow. Recent experiments in 
our laboratory have documented that reduction in skin temperature to values as high as 
27.5C may result in a significant loss in skin blood flow. 
The most important result of the current study is that a reduction in local tissue 
temperature produces a depression in blood perfusion and that it may persist long after 
the tissue is rewarmed from the cooling episode. It is anticipated that continuous 
cryotherapy protocols will hold the state of vasoconstriction as long as cooling is applied, 
with the potential for subsequent persistence. The implications for development of 
ischemia and potential causation of tissue necrosis and neuropathy are serious and, we 
believe, warrant further investigation and a plan for remediation.  
In support of the title of this paper, it is unequivocally clear that the depression of 
skin blood flow that occurs during cryotherapy is tightly coupled with the reduction of 
local skin temperature. In simple terms, the change in blood flow follows the change in 
temperature. However, subsequent to the cessation of active CTU cooling, skin blood 
flow is decoupled from the rising skin temperature and may remain depressed for hours 
under the action of as yet unidentified vasoactive mediators. This condition during which 
the skin blood flow and skin temperature are essentially decoupled becomes 
progressively dangerous during rewarming since as the temperature increases the 
metabolic needs for oxygen and nutrients likewise are greater, but the supply via blood 
flow remains diminished, enhancing the potential for ischemic tissue injury.  
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CONCLUSIONS 
The focal message delivered by this study is that virtually all cryotherapy devices 
that are available commercially have inherent operating conditions that produce a 
vasoconstrictive state having the potential for causing ischemia resulting in injuries such 
as tissue necrosis and neuropathy. The results demonstrate that even short episodes of 
cryotherapy can produce a prolonged vasoconstriction in the local area of treatment. The 
state of vasoconstriction endures long after local temperatures have rewarmed toward the 
normal range, indicating that the existence of vasoconstriction is not associated with 
maintenance of a cold state in the tissue. Following exposure to low temperatures, the 
level of blood perfusion in tissue becomes decoupled from the thermal state. 
Complementary experiments in our laboratory indicate it is likely that a long acting 
humoral agent is released locally with a continuing vasoconstrictive effect long after 
tissue temperatures have rewarmed toward their baseline values. We anticipate that 
further research to confirm, identify and characterize the action of local vasomotive 
agents will aid in understanding and controlling the phenomenon of cold-induced 
vasoconstriction. It would appear that there is a significant opportunity to improve the 
practice of cryotherapy by reducing or eliminating the risk of the provoked persistent, 
possible long term ischemia without compromising the therapeutic efficacy of the 
technique.  
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Chapter 3: Quantitative Evaluation of the Thermal Heterogeneity on 
the Surface of Cryotherapy Cooling Pads2 
ABSTRACT 
We have investigated thermal operating characteristics of 13 commercially 
available cryotherapy units (CTUs) and their associated cooling pads using IR imaging. 
Quantitative examination of the temperature profiles from pad IR images shows diverse, 
non-uniform temperature distribution patterns. The extent of heterogeneity of the 
temperature fields was quantified via standard image analysis methods, including 
thresholding, spatial gradient diagrams, and frequency histogram distributions. A primary 
conclusion of this study is that it is a misnomer to characterize the thermal performance 
of a CTU and cooling pad combination in terms of a single therapeutic temperature. 
MATERIALS & METHODS 
Thirteen commercially marketed CTUs were evaluated as follows: Breg Polar 
Care 300, 500, and 500 Lite (Breg, Carlsbad, CA); DeRoyal T505 and T600 (DeRoyal 
Industries, Powell, TN); Game Ready (Game Ready, Concord, CA); Artic Ice System 
(Pain Management Technologies, Akron, OH); DonJoy Ice man (DonJoy Global, Vista, 
CA); EBIce model 10D (EBI, LLC., Parsippany, NJ ); Össur Cold Rush (Össur 
Americas, Foothill Ranch, CA); and Bledsoe bMini, Cold Control, and bPro (Bledsoe 
Brace Systems, Grand Prairie, TX). Associated CTU brand-specific pads commonly used 
for the knee were tested. Pads were assigned unique identifier codes based on their 
manufacturer, intended application site, and/or geometric shapes. Four-letter identifier 
acronyms applied for reporting results in this study are: knee pads for Polar Care 300, 
                                                 
2 This chapter is based on the manuscript accepted for publication by the Journal of Biomechanical 
Engineering coauthored by Sepideh Khoshnevis, Jennifer E. Nordhauser, Natalie K. Craik, and Dr. 
Kenneth R. Diller [72]. 
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500, and 500 Lite; Game Ready; Arctic Ice; Össur; and Bledsoe Cold Control, bMini, and  
bPro; DeRoyal T505 and T600 U-shaped pad and universal pad; DonJoy McGuire pad 
and universal pad; and EBIce model 10D U-shaped pad, square pad, and two-winged 
“butterfly” pad. Table 3.1 presents a listing of identifier codes for the pad/CTU 
combinations. 
Each CTU and cooling pad combination was evaluated in a dedicated trial using a 
common protocol that followed the manufacturer’s instructions. The cooling pad was 
connected to the CTU, purged of air, laid flat on a carpeted substrate with the therapeutic 
surface designed to face the skin oriented upward, and ice water circulation through the 
pad acitvated. An infrared camera was mounted on a tripod directly above the pad at a 
distance adjusted to ensure the field of view encompassed the full pad area. The trials 
were conducted in a 35 m
2
 laboratory room with air temperature and relative humidity at 
approximately 23C and 50%, respectively. Care was taken to ensure that no ambient 
water vapor condensation collected on the surface of the cooling pad during IR 
temperature measurements that would confound its thermal emissivity properties. 
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Device 
Pad 
Type 
Code 
Flow Rate  
12.5 (cc/min) 
Water Flow Function 
Feed Back 
Control 
Compre-
ssion 
Arctic Ice Universal AION 1200 Continuous None None 
EBIce 
Model 10d 
Butterfly EBOB 1050 
Duty cycle is controlled 
with an analog dial 
None None Square EBOS 1050 
U-Shape EBOU 1125 
Bledsoe 
Cold Control 
Universal BLCN 
1300 
Analog control of flow 
rate 
None None 1425 
1400 
Bledsoe 
Mini 
Universal BLMN 1300 Continuous None None 
Bledsoe Pro Universal BLPN  
Analog control of flow 
rate 
None None 
DeRoyal 
T505 
Universal DRFN 
225-400 (5.1-
6.1 C) 
Duty cycle depends on 
temperature of water 
returning to CTU 
Yes None 
U-Shape DRFU 
DeRoyal 
T600 
Universal DRSN 675-825 
(7.2-8.3 C) 
Similar to DeRoyal 
T505 
Yes None 
U-Shape DRSU 
Össur Cold 
Rush 
Universal OSON 
400 
Analog control of flow 
rate 
None None 650 
775 
Game 
Ready 
Universal GRON 
425 
Analog control of flow 
rate 
None Yes 450 
425 
Polar Care 
500 
 
Universal 
 
PCFN 
 
 
Analog control of flow 
rate 
None None 
Polar Care 
500 Lite 
Universal PCLN  Continuous None None 
Polar Care 
300 
Universal PCTN  Continuous None None 
DonJoy 
Iceman 
Universal DJON  
550 
Continuous with 
analog dial 
None None 
Maguire DJOM 
Table 3.1. Cooling pad/CTU combinations tested, the unique identifier codes, and unique 
operational characteristics. The last letter of the acronym defines the pad type. 
(N=universal, B=butterfly, U=U-shaped, S=square, and M=McGuire) 
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Infrared temperature images of subject pad surfaces were obtained with either a 
FLIR A325sc thermal camera with 320 x 240 pixel resolution and  2C thermal 
accuracy (FLIR Systems Inc., Boston, MA) or a FLIR T650sc with 640 x 480 pixel 
resolution and 1C thermal accuracy (FLIR Systems Inc., Boston, MA) that could 
capture simultaneous infrared and optical images of pad surfaces (the latter system was 
acquired partway through the study). FLIR ExaminIR software (FLIR Systems Inc., 
Boston, MA) was used for initial image processing and analysis of infrared data. The 
thermal radiation emissivity of the pad material was measured using the calculator 
function in ExaminIR for multiple isothermal regions on the surface at room temperature. 
The emissivity was applied in the software to extract temperature values from the thermal 
images. Further image analysis calculations were performed with MATLAB (Mathworks 
Inc., Natick, MA).  
24 AWG type T thermocouples (Omega Engineering, Stamford, CT) were applied 
to monitor and record ambient air and pad surface temperatures in conjunction with 
National Instruments (NI) input modules NI 9211 and 9213 and NI DAQ 9172 and 9174 
and LabView SignalExpress software (National Instruments Corp., Austin, TX). A 
handheld IR thermometer (Fluke 62Max,  1C, Fluke Corporation, Everett, WA) was 
used for further confirmation of pad surface temperatures. The ice water flow rate was 
measured for each CTU and pad combination via an in-line flow meter (Key Instruments, 
Trevose, PA) positioned between the outlet from the ice chest and the pad inlet port. 
Trials were conducted by activating the CTU to circulate ice water through the 
cooling pad. Thermal images of the surface were acquired after the pad reached a steady 
thermal state, which generally required about 10 minutes of operation. Some CTUs 
provided an option for adjusting the water temperature. For these systems, an initial 
steady state was produced at the warmest setting, the thermal data was recorded, and this 
54 
 
process was repeated at incrementally lower settings until the lowest temperature was 
reached. For those devices with intermittent flow, the thermal images were analyzed at 
the completion of the on-phase of the duty cycle after steady state was achieved. 
Thermal images were transferred from the camera to a host computer where they 
were subjected to various enhancement and analysis algorithms to quantify and 
characterize the magnitude and distribution of the temperature variation across the 
cooling pad surface. The first processing step was to establish a threshold temperature 
value in order to isolate the pad area from the warmer background region of an image. 
Given that the highest lateral temperature gradient in an image occurred among the pixels 
at the pad edge, a spatial temperature gradient matrix map was created to identify the 
boundary of the pad. The gradient matrix was generated in the x, y image plane and was 
calculated as the root sum square of the difference between adjacent x and y temperature 
values. The temperature of the pixel with the highest gradient magnitude in the pad edge 
region was set as the threshold value to isolate pad data and filter out background data 
from the initial image. This algorithm showed a very close correspondence between the 
visual and threshold identified boundaries of the pad. The thresholding method always 
successfully removed the background completely. 
A histogram was created to display the pixel occurrence frequencies of specific 
temperatures on the pad surface along with the mean, median, and standard deviation. A 
figure of merit was defined to quantify the extent of nonuniformity in pad temperature by 
removing the outer 10%, 1/e
2
% or 1/e% of the frequency bins from the histogram 
(defining the middle 90%, 86.5% and 63.2% of occurrence frequencies, respectively). 
The range of the remaining bins was defined as a measure of the breadth of temperatures 
occurring on any given pad. Box plots were calculated and drawn for temperature 
variation statistics, providing the inter quartile range (IQR) as an additional metric for 
55 
 
temperature variations on the pad. Important thermal features of the IR image were 
visualized by plots of: temperature contours, spatial temperature gradient magnitude 
maps, and the discrete Laplacian operator (second derivative set to zero, representing an 
edge detection scheme). However, the Laplacian plots did not add any significant insight 
into the extent of pad surface temperature nonuniformity beyond that of the first order 
gradient magnitude and therefore are not included in the analysis presented here.  
The various pads have unique shapes and sizes, and there may be a variety of pad 
configurations for any given CTU. The pads may be matched to the anatomy of the site 
of therapy and the dimensions of the treatment region. The therapeutically effective 
surface area of the pad depends on the pad shape as well as the outline of the treatment 
region. These factors are not constant among different clinical cases, and therefore 
comparison of pad according to their sizes was not included in this analysis. 
RESULTS 
Features of the CTU/pad combinations tested are listed in Table 3.1, including the 
measured water flow rate through the pad, method of control if it existed, and whether the 
CTU/pad was capable of simultaneous pneumatic compression of tissue in the thermal 
treatment area. Although most CTUs produce a constant flow rate of water, some provide 
intermittent flow via an adjustable duty cycle. For example, ice water flow to the cooling 
pad for the EBIce model 10D is regulated manually, whereas the DeRoyal T505 and 
T600 have a feedback control mechanism based a comparison of the temperature of water 
returning from the pad to a set point value.  
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Figure 3.1. Optical (A and C) and IR (B and D) images of Bledsoe Universal (A and B) 
and EBIce model 10D butterfly pads (C and D). The symbols * and O in (A) demark 
alternate parallel water flow pathways. 
The optical and IR images in Figure 3.1 for a universal cooling pad from Bledsoe 
(BLMN) and of an EBIce knee cooling pad (EBOB) illustrate contrasting temperature 
patterns that may be encountered. A pseudocolor bar for the IR images shows the range 
of temperatures on the subject pad, with the extreme values denoted numerically. By 
casual visual inspection, the Bledsoe Universal pad appears to be more thermally uniform 
than the EBIce Butterfly pad. In both IR images there is a thermal halo effect surrounding 
the pad owing to lateral cooling of the underlying carpet substrate. This phenomenon is 
A B 
C D 
* * 
* 
O O 
O 
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more obvious for the Bledsoe pad than the EBIce pad due to the former’s greater thermal 
homogeneity and, perhaps, a lower level of thermal insulation on the back of the pad.  
 Min Max Mean 
Average Pad 
Temperature 
2.6 10.9 6.8  2.5 
Coldest Temperature 0.7 7.9 4.4  2.4 
Warmest Temperature 11.1 17 14.5  1.7 
Breadth  
(10% exclusion) 
2.0 9.1 5  2.3 
Breadth  
(1/e
2
% exclusion) 
1.7 8.2 4.2  2.0 
Breadth  
(1/e% exclusion) 
0.5 5.3 1.8  1.3 
IQR 0.8 4.2 1.9  1.2 
Table 3.2.  Aggregate thermal data of cooling pad surface temperature distributions for 
all trials  
Table 3.2 presents a summary of the ranges of steady state spatial temperature 
distributions measured on the various subject cooling pads. This data includes the lowest, 
highest, average and standard deviation of the local temperatures, plus the minimum, 
maximum, average, standard deviation, and IQR of the temperature ranges. The coldest 
temperature measured was 0.7°C on the Össur pad, and the mean and standard deviation 
of all average temperatures was 6.8  2.5°C. Determination of the range of temperatures 
over the surface by the 10%, 1/e
2
% and 1/e% methods (defining the middle 90%, 86.5% 
and 63.2% of occurrence frequencies, respectively) provides a more insightful 
discrimination among pads (described later in the Results section). The highest value for 
IQR occurred on the EBIce butterfly pad (4.2C), and the lowest value on the DonJoy 
universal pad (0.8C). 
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Figure 3.2 presents temperature contours and the temperature gradient map for the 
EBIce butterfly pad. In the IR image, the temperature of the background region was set to 
the threshold value to increase the visible thermal resolution on the pad. The pad 
temperature covers the range of 4-14C, with a significant portion of the surface above 
12C. The temperatures of areas that directly overlay water flow channels are 4-7C. 
Regions on the pad having the largest magnitude of lateral spatial temperature gradient 
are located primarily along the outer margin the edges of water flow pathways.  
 
 
Figure 3.2. IR image of EBIce model 10D butterfly pad (left) and its gradient magnitude 
map (right). The color bars show temperatures (C) for the IR image and (C/pixel) for 
the gradient map. 
Histograms were created to provide a graphical representation of the occurrence 
frequency of specific temperatures on the surface of each pad tested. Two exemplar 
histograms are shown in Figure 3.3. The EBIce butterfly pad histogram exhibits a skewed 
distribution with a relatively large degree of thermal non-uniformity.  The Bledsoe Cold 
Control pad also demonstrates a skewed distribution, but with a significantly more 
homogeneous pattern. The top, middle and bottom histograms indicate the temperature 
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ranges for the outer 10%, 1/e% and 1/e
2
% of values. Note that the vertical frequency 
scales are different for the two systems, reflecting the difference in relative tightness of 
the two temperature distributions.  
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Figure 3.3. Histograms of pad temperature distributions with the outer 10%, 1/e
2
%, and 
1/e% of values excluded as indicated by unfilled bars. Upper panels are for EBIce model 
10D butterfly pad, and lower panels for Bledsoe Cold Control universal pad. 
 
 
 
61 
 
Figure 3.4 shows an explicit contrast between the relative spread of temperatures 
for the EBIce butterfly and Bledsoe Cold Control universal pads. The 10% breadth 
margins for both pads are marked on their corresponding plots. This representation of the 
data clearly illustrates the very large differential in variance of temperatures that may 
occur over two different pad surfaces. Data presented in this format enables a graphic 
assessment of the relative temperature heterogeneity among multiple CTU/pad systems. 
 
 
Figure 3.4. Direct comparison of the relative spread of temperature distributions for the 
Bledsoe Cold Control knee pad and EBIce model 10D butterfly pad. The stars and 
squares mark the 10% breadth limits for the two pads. 
Another differentiating feature among the various CTU/pad combinations is 
whether the ice water flow is continuous or intermittent, the latter of which will produce 
oscillating pad temperatures even after a steady operating state is reached. Figure 3.5 
presents histograms of EBIce Model 10D butterfly pad (EBOB) temperatures at the 
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beginning and end of one water flow cycle. The overall temperature drops during active 
water flow and increases to a bimodal distribution when the water flow is off, reflecting 
the pattern of passive heat transfer with the environment.   
 
Figure 3.5. Change in the temperature distribution on the EBIce butterfly pad at the 
beginning and end of the gated-on portion of an intermittent flow duty cycle with the 
controller adjusted to the coldest setting. 
Figure 3.6 presents box plots of the pad temperature statistics for all devices 
tested (see Table 3.1 for identifier codes). Each box plot displays the maximum, 
minimum, first and 3
rd
 quartiles, and median of pad temperatures for one CTU/pad 
operation. This data shows that the EBIce model 10D butterfly pad (EBOB) and 
DeRoyalT505 universal pad (DRFU) have the most non-uniform temperatures, with 
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interquartile ranges (IQR) of about 4C. In contrast, the Bledsoe Cold Control (BLCN) 
and DonJoy Iceman (DJON) have an IQR of only 0.8C.  
 
Figure 3.6. Box plots of pad temperature distribution statics for the indicated CTU/pad 
combinations 
Some CTUs offer a feature for the user to adjust the intensity of cooling provided 
by the system. The mechanism for implementing this feature involves modulation of the 
water flow through the cooling pad by one of various methods. The question arises as the 
extent to which adjustment of the CTU control actually changes the temperatures 
produced on the cooling pad. CTUs having this feature were operated at high, 
intermediate and low settings, and the resulting temperature distributions were measured 
on their cooling pads. Data from these trials is presented in Figure 3.7.  In general, CTUs 
with a cooling adjustment at best had a nonlinear relationship between the controller 
setting and the pad temperature, and in some cases, the controller exerted no perceptible 
effect on pad temperatures. For example, the Össur Cold Rush (OSON) and Polar Care 
500 (PCFN) CTUs manifest no change in pad temperatures for controller adjustments 
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across their entire range. The Bledsoe Cold Control (BLCN) temperature decreased by 
more than 5ºC between the warmest and intermediate settings, but there was not 
significant change in pad temperature for colder settings. The existence of the control 
adjustment sends an implicit message to the user that altering the setting will produce a 
significant change in thermal performance, whereas data shows that not to be the case for 
many systems.  
 
 
Figure 3.7.  The effect of adjusting the user-controlled temperature setting on measured 
pad temperature ranges. The plots show the low, median and high values. Data are 
grouped by device type, with right and left plots for the designated coldest and warmest 
settings, respectively. Central plots denote intermediate control settings. 
DISCUSSION 
Over the course of our extensive past testing of CTUs we have consistently 
observed significant lateral temperature variations on the skin underlying a cooling pad. 
These measurements were obtained from multiple simultaneous thermocouple readouts 
or by pulling a single thermocouple laterally on the skin under a cooling pad. However, 
this temperature data was obtained mainly on an anecdotal basis, without the benefit of 
continuous two dimensional temperature maps afforded by IR imaging.  Since 
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cryotherapy is driven by the temperature applied to the skin surface, the present study 
was undertaken to measure how large the lateral thermal differences may be on the 
cooling pad surface of selected CTU systems. The drawback in using IR imaging is that it 
is not possible to obtain continuous reading of skin temperatures. However, the cooling 
pad defines the thermal boundary condition applied to the skin during cryotherapy, and 
consequently the IR images do provide information relevant to understanding the 
physiological response to application of a cryotherapy system.  
We have observed that in addition to the thermal boundary conditions imposed by 
a cooling pad, local features of anatomical structure and circulatory function may 
contribute to variations in skin temperature at a cryotherapy site. Therefore, this study 
was explicitly confined to only measuring the potential effects of the cooling device in 
defining the thermal boundary conditions that may be applied to the skin surface during 
cryotherapy.  
Eighteen different CTU and cooling pad combinations were evaluated with an 
infrared camera to determine the extent to which they were able to create a uniform 
temperature field for cryotherapy. As anticipated, all systems produced thermal profiles 
that varied by location on the pad surface. Since cooling is caused via the circulation of 
ice water through channels integral to the pad, an inherent consequence of this style of 
cooling system is that there will be thermal dead spaces interspersed between the 
channels. Cooling pads are fabricated from flexible polymeric sheets that have relatively 
low thermal conductivity. Therefore, the lateral distribution of the cooling effect of ice 
water flowing through the pads is limited. The thermal images and temperature gradient 
maps quantify this effect for the various systems.  
Thermal distinctions among CTU/pad systems appear to be primarily due to the 
design of the water flow pathways through individual pads and the method by which a 
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CTU pumps water through a pad. The temperature variation across a single pad varied 
greatly from one pad to another. A comparison of the temperature variation magnitude 
amongst different pads showed a maximum ratio of about 5 to 1.Thus, these unique 
design features can be quite substantial. 
Ultimately, the utility of cryotherapy relates to its ability to improve the healing of 
soft tissue injuries, and this role has long been acknowledged. There is vast empirical 
documentation and experience supporting the value of cooling injured tissues, but there is 
far from a complete quantitative picture of the underlying mechanisms of action. It is 
recognized that a key action of cryotherapy is to reduce the rate of blood flow to the 
target tissue as the temperature is lowered. The sensitivity of the physiological response 
to an applied cooling temperature as portrayed in terms of modulation in skin blood 
perfusion has been measured in experiments parallel to those described in this paper and 
is reported in other publications [52,73,74]. The coupling between an applied therapeutic 
temperature and the changes produced in skin blood flow is a key component dictating 
the efficacy of cryotherapy regimens. The data presented herein for the thermal qualities 
of cryotherapy devices is complementary to designing cooling therapies to elicit desired 
physiological responses to improve tissue healing processes.   
CONCLUSIONS  
CTUs are widely applied to provide localized therapeutic cooling for soft tissue 
injuries, and their thermal performance is frequently expressed in terms of a single 
representative temperature. This study has documented that all CTU cooling pads instead 
create a finite range of temperatures that will be transmitted to the skin. Furthermore, 
there are substantial differences in the magnitude, range and distribution of temperatures 
over the cooling pad surface among the various CTU/pad combinations tested. As a 
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result, use of a single value to represent the general applied therapeutic temperature is not 
justified. A more useful characterization of the thermal performance of the CTU/pad 
combination would be the minimum temperature and the range of temperatures produced 
on the pad. Although some devices are equipped with a user-controlled adjustment for the 
pad temperature, often the resulting overall effect on thermal performance of the device is 
far less than the inherent spatial variations in temperature across the cooling pad surface. 
In summary, care and insight should be exercised in prescribing the user protocols of 
CTUs based on nominal thermal performance specifications, based on an awareness of 
the temperature producing characteristics of a particular device.  
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Chapter 4: Cold-Induced Vasoconstriction May Persist Long After 
Cooling Ends: an Evaluation of Multiple Cryotherapy Units3 
ABSTRACT 
Purpose: Localized cooling is widely used in treating soft tissue injuries by 
modulating swelling, pain and inflammation. One of the primary outcomes of localized 
cooling is vasoconstriction within the underlying skin. It is thought that in some instances 
cryotherapy may be causative of tissue necrosis and neuropathy via cold-induced 
ischemia leading to nonfreezing cold injury (NFCI). The purpose of this study is to 
quantify the magnitude and persistence of vasoconstriction associated with cryotherapy.  
Methods: Data is presented from testing with four different FDA approved 
cryotherapy devices. Blood perfusion and skin temperature were measured at multiple 
anatomic sites during baseline, active cooling, and passive rewarming periods.  
Results: Local cutaneous blood perfusion was depressed in response to cooling 
the skin surface with all devices, including the DonJoy (DJO, p = 2.6 x 10
-8
), Polar Care 
300 (PC300, p = 1.1 x 10
-3
), Polar Care 500 Lite (PC500L, p = 0.010), and DeRoyal 
T505 (DR505, p = 0.016). During the rewarming period, parasitic heat gain from the 
underlying tissues and the environment resulted in increased temperatures of the skin and 
pad for all devices, but blood perfusion did not change significantly, DJO (n.s.), PC300 
(n.s.), PC500L (n.s.), and DR505 (n.s.).  
Conclusions: The results demonstrate that cryotherapy can create a deep state of 
vasoconstriction in the local area of treatment. In the absence of independent stimulation, 
the condition of reduced blood flow persists long after cooling is stopped and local 
temperatures have rewarmed toward the normal range, indicating that the maintenance of 
                                                 
3 This chapter is based on the manuscript accepted for publication by Knee Surgery, Sports, Traumatology, 
Arthroscopy coauthored by Sepideh Khoshnevis, Natalie K. Craik and Dr. Kenneth R. Diller [73]. 
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vasoconstriction is not directly dependent on the continuing existence of a cold state. The 
depressed blood flow may dispose tissue to NFCI. 
Keywords: cryotherapy; vasoconstriction; tissue blood perfusion; tissue cooling; 
nonfreezing cold injury. 
MATERIALS AND METHODS 
Experiments were conducted on FDA approved, commercially available 
cryotherapy devices, namely: BREG Polar Care 300 (PC300; BREG, Carlsbad, CA), 
BREG Polar Care 500 Lite (PC500L; BREG, Carlsbad, CA), DeRoyal T505 (DR505; 
DeRoyal Industries, Powell, TN), and DonJoy Ice man 1100 (DJO; DonJoy Global, 
Vista, CA). Similar tests were conducted on other CTUs issuing in consistent results, 
although not in statistically significant numbers to warrant reporting herein: BREG Polar 
Care 500 (BREG, Carlsbad, CA), DeRoyal T600 (DeRoyal Industries, Powell, TN), 
Game Ready (Game Ready, Concord, CA), Artic Ice System (Pain Management 
Technologies, Akron, OH), Aircast Cryo/Cuff (DonJoy Global, Vista, CA), EBIce 
Controlled Cold Therapy 10D (EBI, LLC., Parsippany NJ), Bledsoe bMini 
(BledsoeBrace Systems, Grand Prairie, TX), Bledsoe bPro (BledsoeBrace Systems, 
Grand Prairie, TX), and Bledsoe Cold Control (BledsoeBrace Systems, Grand Prairie, 
TX). 
The CTUs tested in this study were available only on a temporary basis that we 
did not control and that therefore dictated the scheduling of specific trials. Subjects were 
assigned to trials as a function of the CTU time-wise availabilities. Accordingly, the 
study was conducted in three sequential phases. In the first phase three subjects each 
underwent three single trials using three different CTUs (DJO, PC300, and PC500L).  
The resulting data was subjected to repeated measure analysis using the Friedman test. 
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Nine subjects were recruited for the second phase and randomly assigned to a single trial 
on one of three different CTUs (DJO, PC300, and DR505) so that each CTU was tested 
three times. The data was assessed via independent study analysis using the Kruskal-
Wallis test. For the third phase seven subjects were assigned to a single trial with a DJO 
CTU and a test site at either the knee or the foot/ankle. The data from these experiments 
was analyzed using the independent t-test. Some subjects participated in multiple phases 
of the study. No more than one trial was conducted per week on any given subject. 
Individual subjects were included in various specific trials as a function of their shared 
time-wise availability with the various CTUs to be tested, in combination with the need 
for distribution of the subjects among different trials to satisfy the requirements for 
statistical analysis of data. 
Subjects were recruited from the University of Texas at Austin faculty and student 
body and were screened for contraindications of cryotherapy described by Rheinecker 
[75] and Lee et al.[14], including use of vasoactive medications, pregnancy, or a fresh 
wound at the site of cooling. The demographic data and assignment of protocols is 
presented in Table 1.   
The basic research protocol consisted of applying CTUs to human subjects and 
measuring changes in the skin temperature and blood perfusion in a targeted treatment 
area before, during, and following a period of active cooling. The protocols were 
designed and implemented to mimic typical prescribed uses of the devices.  
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Device Type DonJoy (DJO) 
Polar Care 
300 
(PC300) 
DeRoyal 
T505 
(DR505) 
Polar Care 500 
Lite (PC500L) 
Number of 
Subjects 
n=8 n=4 n=3 n=3 
Subject IDs S1,S2,S3,S6,S7,S8,S9,S12 S1,S3,S4,S7 S3,S6,S11 S1, S3, S7 
Site of Cooling 
Knee (n=3), 
Foot/Ankle (n=4), 
Shoulder (n=1) 
Knee (n=4) Knee (n=3) Knee (n=3) 
Cooling Duration 
(min) 
55.3  ± 8.4 59.4 ± 3.0 92.8 ± 24.1 61.0 ± 1.2 
Gender F(3) M (5) F(2) M (2) F(2) M (1) F(2) M(1) 
Age (years) 33.0 17.4 38.8 21.6 36.0 14.0 44.3 ± 22.6 
BMI (kg/m
2
) 22.7  3.3 22.8  4.7 20.8  3.0 22.5 ± 5.7 
Table 1   Demographic data and experimental protocols by device type 
Instrumentation 
The data presented in this paper was collected using MoorVMS-LDF2 laser 
Doppler blood perfusion and temperature probes (Moor Instruments, Millwey, 
Axminster, Devon, UK) with a flux accuracy of 10% of magnitude for perfusion and an 
accuracy of ± 0.3°C for temperature, based on manufacturers’ specifications [76]. The 
Moor probes measure perfusion within the superficial 0.5 mm of tissue [77]. Thin ribbon 
or small bead thermocouples (Omega Engineering, Stamford, CT) were used to monitor 
temperature flux (± 0.1°) at multiple sites. Each sensor was mounted directly onto the 
skin beneath the site of the cooling pad. Blood pressure was monitored intermittently 
with a sphygmomanometer, and the values were applied to calculate cutaneous vascular 
conductance (CVC) to represent skin perfusion [59]. 
National Instruments (NI) input modules 9201, 9205, 9211, and 9213 (National 
Instruments, Austin, TX) were used to acquire blood perfusion and temperature data from 
the sensors, and NI DAQ 9172 and 9174 were used as a computer interface. Data was 
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collected with a sampling rate of 12 Hz. Temperature data was subsequently down 
sampled to 4 Hz, a rate that prevented aliasing.  
Figure 4.1 shows sequential stages of the subject preparation, including placement 
of sensors, application of an ACE wrap as a thermal barrier, and positioning of the 
cooling pad. Additional thermocouples measured temperature on the cooling pad surface, 
ice water bath, and room air. In some instances, temperatures of the ice water flowing at 
the pad inlet and outlet were monitored with inline thermocouples.  
 
Figure 4.1    Photographs of thermocouples (T), heat flux gauge (HFG), and LDF2 probes 
(P) applied to the ventral aspect of the right knee (A).  Same location after application of 
a single thermal insulation layer (ACE bandage wrap) with no elastic stretching (B) and 
after application of a PC300 cooling pad over the insulation layer (C). 
Experimental protocol 
Each experiment was composed of 3 instrumented sequential segments:  1) 
baseline, 2) active CTU cooling, and 3) passive rewarming with the CTU pump off. 
Subjects were in a semi recumbent position during the experiments and were asked to 
  a 
a
 b   c 
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minimize physical movements of the test site to avoid creating motion artifacts in the 
laser Doppler perfusion data. All experiments were performed at a fixed room 
temperature (220.5°C) and humidity (50% r.h.) environment. At least 1 hour was 
provided to acclimate to ambient conditions while being instrumented. A blanket was 
applied at subject request to prevent global vasoconstriction from ambient air exposure. 
Data extraction 
Data was grouped into five minute segments beginning with the start of the 
rewarming period. Perfusion data was represented by the median value for the associated 
time segment. The baseline value was calculated over the last five minutes of that period. 
All perfusion values were normalized to the baseline. When data was available, the 
perfusion measurements at multiple different locations were averaged. 
Extraction of data was performed by a single researcher who is not an author 
using a Matlab (MATLAB7.10, The MathWorks Inc., Natick, MA) program that 
automatically isolated all necessary data, with the exception of manually marking the 
start and end points of the cooling period. To independently verify the integrity and 
accuracy of this process, extraction from the same data sets was repeated by two 
additional researchers within the lab, one of whom is not an author, and intraclass 
correlation was used to compare their findings using SPSS (Statistical Package for Social 
Science, IBM SPSS Version 20.0 for Windows; IBM Corp, Armonk, NY) software. 
This study and all related protocols were approved by the University of Texas 
Institutional Review Board (IRB UT #2011-05-0106). 
Statistical Analysis  
A major challenge for statistical analysis was the small sample size (n=3) of the 
data. Among various available tests for normality, the Shapiro-Wilk [78] is the most 
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suitable for small samples. However, it carries a very low power for small n, such as 
P<20% for n = 10 [79]. The same limitation is true for the Kolmogorov-Smirnov, 
Lilliferos and Anderson-Darling tests. Therefore, for data analysis we chose to use 
nonparametric tests which do not require the assumption of normality. Nonparametric 
tests, such as Friedman and Kruskal-Wallis, were used whenever possible. Since there is 
no accepted non-parametric equivalent for a t-test, it was used as needed. 
The DonJoy cryotherapy experiments consisted of four to the foot and ankle, 
three to the knee, and one to the shoulder. The minimum perfusions achieved during 
cooling were compared between the foot/ankle and knee experiments through unpaired t-
tests (Matlab) to evaluate the effect of these anatomic locations on the vascular response 
to cold exposure.  
Friedman and Kruskal-Wallis tests were performed to evaluate minimum 
perfusion values for all devices on the knee to determine whether significant differences 
existed. Pairwise comparison using paired t-tests was also performed between the 
perfusion values for adjacent time points to evaluate transient changes in blood flow. 
One-sample t-tests were used to quantify the significance of changes in perfusion 
during cooling relative to baseline. G*Power version 3.1 was used to calculate sample 
size for a significance of 0.05 and power of 0.95 [80,81], which was n = 3. 
Dunnett’s test was applied in SPSS to evaluate the extent of perfusion change 
during rewarming. Values from the first 5 minutes of rewarming for each trial were 
compared to those at subsequent times in a case-control fashion. This same analysis was 
also performed to evaluate changes in temperature during rewarming.  
Plots of standard error were used to determine the degree of overlap among 
perfusion values during the rewarming period, and a linear mixed model regression 
analysis was applied to evaluate the general trends. This type of analysis was used since 
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the data included measurements involving different rewarming durations for subjects. 
Unlike general linearized regression analysis, linear mixed model regression does not 
stipulate independence and allows for missing data at later time points. Time was 
assigned to be a fixed effect in this analysis to determine whether a perfusion trend 
occurred. Time was assigned to be a random effect to check for non-independence. 
RESULTS 
Cooling pad and skin surface temperatures and skin blood flow data for an 
exemplar protocol are shown in Figure 4.2 to illustrate the temporal characteristics of the 
data. Notice how the perfusion falls with decreasing temperature but does not follow the 
subsequent trend of increasing temperature. 
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Figure 4.2   Data for a trial with a BREG Polar Care 300 cryotherapy unit applied to the 
knee, consisting of 30 minutes of baseline data, followed by 60 minutes of active cooling, 
and 84 minutes of passive rewarming. Temperature histories measured at two locations 
on the skin surface under the cooling pad (red and green) and on the surface of the pad 
(blue) (A). Perfusion histories at the two sites in the skin under the cooling pad (B).  
a 
b 
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Effect of Anatomical Location  
An independent t-test performed between the DJO data for the knee (n = 3) and 
foot/ankle (n = 4) revealed no significant difference in the extent of vasoconstriction 
between these locations (n.s.).  
Comparison among CTU Devices 
Both dependent and independent statistical analyses were applied to analyze the 
degree of vasoconstriction induced by different CTU devices. A Friedman test was 
performed to compare the vasoconstriction in subjects (n = 3) who all used the DJO, 
PC300, and PC500L. A Kruskal-Wallis test was performed to compare the extent of 
vasoconstriction among independent groups (n = 3) who used the DJO, PC300, or 
DR505. No significant differences were found (α = 0.05, n.s.). Table 4.2 presents a 
summary of statistics comparing the various CTU and anatomical combinations. 
 
Phase Device 1 Device 2 Device 3 Test Type p Value Body Part 
Subject 
Assignment 
1 DJO PC300 PC500L Friedman 1 knee S1, S3, S7 
2 
DJO 
PC300 
 
 
DR505 
Kruskal-Wallis 0.56 knee 
S2, S6, S8 
S1, S3, S4, S7 
S3, S6, S11 
3 DJO DJO N/A 
Independent   
t-test 
0.93 
knee 
foot/ankle 
S3, S7, S9 
S1, S2, S8, S12 
Table 4.2   Summary of experiments and statistical tests used to analyze data. Subject 
assignments are indicated by common alignment with the test identifier. 
Effect of Cooling on Depression of Blood Perfusion 
One sample t-tests confirmed that a significant difference existed between 
baseline and minimum perfusion values caused by cooling (Table 4.3).  
78 
 
CTU p Value n 
DJO 2.6 x 10-8 8 
PC300 0.0011 4 
PC500L 0.01 3 
DR505 0.016 3 
Table 4.3   Results of one sample t-test showing the significant drop in perfusion in 
response to localized cooling 
Transient Gradients in Perfusion during Rewarming 
Pairwise comparison for all devices between perfusion at adjacent 5 min periods 
during rewarming showed that no significant differences (α = 0.05) except for single 
points on DJO for 5 and 10 min (p = 0.033) and PC300 for 10 and 15 min (p = 0.045).  
Persistence of Vasoconstriction during Rewarming 
A case control study for all devices used Dunnett’s test to compare current and 
subsequent perfusion values and showed that there was no significant increase in blood 
perfusion during the observed rewarming period for any of the cryotherapy devices. The 
mean and standard deviation of perfusion were calculated for the PC300 and DJO data 
over each 5 minute rewarming interval showing that there was no net accrued increase in 
perfusion. Figures 4.3 (a) and (b) respectively show the aggregate calculated PC300 and 
DJO data that document the absence of change in perfusion during rewarming. 
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Figure 4.3   Mean and standard errors of perfusion values from the PC300 (A) and  DJO 
(B) cryotherapy devices during 90 and 95 minutes of rewarming, respectively. The 
overlap among the error bars shows that there is no overall significant change in 
perfusion during rewarming. 
A 
B 
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Mixed Model linear regression analysis was performed on this rewarming data to 
derive the regression equations presented in Table 4.4. 
 
CTU Regression Equation p value Duration (min) 
DJO y = 0.00017x + 37 0.997 95 
PC300 y=-0.024x + 50 0.807 90 
DR505 y = -0.036x + 44 0.81 20 
PC500L y = -2.6x + 98 0.40 15 
PC500L y = -0.20x + 52 0.70 120 
Table 4.4   Linear regression equation describing the change in perfusion during passive 
rewarming period 
Increase in Temperature during Rewarming 
A case control analysis via Dunnett’s test compared the temperature at the start of 
rewarming and subsequently. It showed a significant increase after 15 and 30 minutes for 
DJO and PC300, respectively. Although temperature showed an increasing trend for both 
DR505 (5.5ºC in 20 minutes) and PC500Lite (3.5ºC in 15 minutes), the increase was not 
significant by this measure. The results are in Table 4.5. 
 
CTU Metric 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 
DJO Perfusion                    
Temperature                    
PC300 Perfusion                    
Temperature                    
DR505 Perfusion                    
Temperature                    
PC500L Perfusion                    
Temperature                    
Table 4.5   The persistence of vasoconstriction and reduced temperature during 
rewarming period based on the case control study using the Dunnett’s test. The numbers 
define the time in minutes from the start of rewarming period. The shaded areas show the 
region where no significant increase in either skin perfusion or temperature takes place. 
For PC300, DR505 and PC500L the rewarming only lasted for 90, 20 and 15 minutes, 
respectively. 
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Data Extraction Reliability 
A single rater (who is not an author) performed the extraction for all data reported 
herein. This work was verified via partial replication by two other raters (one not an 
author) and compared by Intraclass Correlation (ICC) analysis. The ICC values were 0.97 
for the minimum perfusion data, 0.97 at 5 minutes and 0.99 at 30 minutes later. Fleiss 
ranks ICC values over 0.75 as excellent [82]. Flack et al. and Walter et al. associate our 
ICC values and number of trials with a power of at least 0.98 [83–85].  
DISCUSSION 
The most important finding of the present study was that following the large drop 
in blood perfusion caused by surface cooling of soft tissue, in the absence of an imposed 
stimulation the perfusion will remain depressed for an extended time even while the 
tissue temperature is returning toward baseline. To our knowledge, this phenomenon has 
not been identified in prior studies of the effects of cryotherapy.  
No obvious anatomical differentials in the response to cryotherapy were detected. 
There would appear to be a common local vasomotive control mechanism. The 
vasoconstriction response to surface cooling appears to be ubiquitous. Thus, the site of 
cooling application is not considered as a distinguishing factor in this data set.  
There was no significant difference in the extent of vasoconstriction induced by 
the different devices tested: DJO, PC300, PC500L, and DR505. These statistical results 
suggest that device type does not significantly affect the level of vasoconstriction induced 
by cryotherapy. The response to other ice water circulating CTUs that we have measured, 
but not reported herein, is fully consistent with these results. 
Primary limiting factors in the present study are that blood perfusion and 
temperature measurements were performed only at singular locations, inherently missing 
the two dimensional distributions of these properties across the entire treatment area. We 
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have casually observed that anatomical structures such as the knee patella may influence 
both temperature and perfusion, but explicit data that document this effect remain to be 
acquired owing to limitations of our current instrumentation. We have made two 
dimensional temperature measurements via IR thermography at a single time point that 
will be included in subsequent publications. Also, the blood perfusion probes have an 
approximately 1cm vertical height, meaning that where they are positioned, the cooling 
pad is locally held away from the skin surface, resulting in a reduced cooling effect. The 
temperatures measured with the perfusion probe thermal sensor are approximately 2 - 
3°C warmer during cooling than sensed by thermocouples at peripheral sites directly 
below the pad. Thus, the dose response effect of cryotherapy on blood flow is 
compromised. This phenomenon has been quantified and will be reported in a subsequent 
publication under preparation. 
There are few published studies that have systematically analyzed the 
microcirculatory modification effects of cryotherapy and still fewer that have been 
conducted on human subjects. One such human subject study concluded that cryotherapy 
results in a significant decrease in superficial (2 mm depth) and deep (8 mm depth) 
microcirculatory blood flow during a 30 minute cooling period [22], consistent with our 
findings. But, post-cooling perfusion measurements were not recorded. 
Another study in rats showed that 20 minutes of cryotherapy caused a significant 
decrease in perfusion [86]. Contrary to our findings, the blood flow depression did not 
persist following the cessation of active cooling. However, this study measured perfusion 
in deeper skeletal muscular and only at relatively infrequent intervals. 
The data from this study indicate that it is likely that a long acting humoral agent 
is released locally with a continuing vasoconstrictive effect that persists while tissue 
temperatures rewarm toward the baseline values. We are pursuing further research to 
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confirm, identify, and characterize the action of local vasoactive agents with the objective 
being to better control cryotherapy-induced tissue ischemia.  
A focal message delivered by this study is that many commercially available 
cryotherapy devices have inherent operating conditions that produce a significant degree 
of vasoconstriction that may last long after cessation of cryotherapy. The experimental 
results show an uncoupling between skin perfusion and temperature during the passive 
rewarming period. The extent of vasoconstriction and its prolongation are sufficient to 
possibly lead to an equivalent ischemic state and then to NFCI.  
CONCLUSION 
The results demonstrate that standard cryotherapy methods produce a significant 
and persistent state of vasoconstriction in the local area of treatment during both active 
cooling and subsequent passive rewarming. The data presented in this paper that extend 
the understanding of the response in blood perfusion to cryotherapy may be embodied in 
improved therapeutic schemes to reduce the risk of ischemic injury.  
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Chapter 5: Persistent Vasoconstriction After Cutaneous Cooling: 
Hysteresis Between Skin Temperature and Blood Perfusion4 
ABSTRACT 
Localized cooling is commonly used to manage soft tissue injury by reducing 
pain, swelling and inflammation and may also result in prolonged skin vasoconstriction at 
the treatment site.. The goal of this study was to investigate the persistence of cold-
induced vasoconstriction following cessation of active surface cooling and the resulting 
temperature-driven hysteresis in skin perfusion over the cooling and rewarming cycle. An 
Arctic Ice cryotherapy unit was applied for 60 minutes of active cooling followed by 120 
min of passive rewarming to the knee region of 6 healthy subjects. Multiple laser Doppler 
flowmetry perfusion probes were used to measure skin blood flow (expressed as 
cutaneous vascular conductance, CVC) during the experiments. Surface cooling produced 
a significant reduction in CVC (p < 0.001). The Dunnett’s test, repeated measure 
ANOVA, Friedman test, and mixed model regression analysis all showed the persistence 
of vasoconstriction throughout the rewarming period. The occurrence of a hysteresis 
effect between CVC and skin temperature during cooling and rewarming cycle of the 
skin was calculated to be significant (p < 0.005). Mixed model regression showed a 
significant difference in the slopes of the CVC-skin temperature curves during cooling 
and rewarming (p<0.0005). Localized cooling causes significant vasoconstriction that 
continues beyond the active cooling period during a significant subsequent rewarming of 
the skin. 
 
                                                 
4 This chapter is based on the manuscript readied for submission to the Journal of Applied Physiology and 
is coauthored by Sepideh Khoshnevis, Natalie K. Craik, Dr. R. Matthew Brothers and Dr. Kenneth R. 
Diller. 
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INTRODUCTION 
Localized cooling (cryotherapy) of soft tissue is commonly applied following 
orthopedic surgery and sports injuries to reduce pain, swelling, inflammation, bleeding, 
and secondary hypoxic injury. Cryotherapy may be  used in conjunction with 
cryokinetics by physical therapists to reduce the sensation of pain and to allow early 
mobilization [3,6]. Although cryotherapy has been adapted widely, protocols largely have 
been derived empirically, and many diverse operational methods are recommended [24].  
Cooling sources requisite for cryotherapy include cubed or crushed ice [15], 
refrigerated gel packs[16], and commercially available cryotherapy units (CTU) that are 
distinguished by the ability to provide prolonged cooling episodes [15,20,21]. A CTU 
generally consists of an insulated chest that is filled with ice and water, a cooling pad, a 
submersible water pump, and tubing that connects the pad to the pump. A user is 
instructed to maintain the chest with ice and water per the manufacturer’s 
recommendations. For these CTUs, the cryotherapy temperature is based on the melting 
state of water (0C), and the duration prescribed for a single application episode may 
vary from minutes [7,8,14] to days [9,19,25,87]. A more sophisticated and sensitive, 
albeit expensive, approach to regulating the temperature of CTU cooling water is via a 
thermoelectric refrigeration source to replace the ice.  A circulating water cooling pad 
consists of a pair of flexible polymeric sheets having inlet and outlet ports connecting 
moulded flow channels that direct the movement of cold water over a treatment surface in 
a specific geometric pattern. Many different pad designs exist, giving rise to unique 
temperature patterns on the treatment area [72].  
Localized cooling of non-glabrous skin results in vasoconstriction through 
activation of vasoactive pathways [37–41]. Prolonged cold-induced vasoconstriction may 
result in tissue ischemia leading to non-freezing cold injury (NFCI) 
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[42,45,46]Furthermore, reestablishing tissue blood flow following a prolonged period of 
tissue ischemia may result in reperfusion injury [47]. There are sundry reports in the 
literature of ischemic cryotherapy related injuries ranging from ice burn [88] to full 
thickness skin necrosis [13,14] and nerve damage [10,89,90]. 
Despite the widespread use of cryotherapy and the occurrence of related injuries, 
the relationship between skin temperature and tissue perfusion during the cooling and 
subsequent rewarming periods remains relatively unknown. Therefore, the goal of this 
study was to investigate the relationship between skin temperature and CVC during and 
following localized cooling of non-glabrous skin with a commercially available CTU. We 
hypothesize that there exists a hysteresis between CVC and skin temperature during the 
cooling and rewarming phases of cryotherapy in the absence of artificial external stimuli. 
METHODS 
Ethical Approval and Subjects 
This study was approved by the Institutional Review Board of The University of 
Texas at Austin prior to start of experiments. All subjects provided voluntary written 
consent to participate after being informed about the nature of the experiments and their 
possible side effects.  
The experiments were performed on 6 healthy non-smokers (3 male) with an 
average age ( SE) of 22.5  1.4 years and BMI ( SE) of 23.4 ± 1.6 kg/m2. All subjects 
were free from any known cardiovascular, metabolic, or neurological disease and were 
not taking any medication. None of the subjects reported a history of cryotherapy or other 
form of cold exposure in the lower extremities for at least a year prior to the experiment 
and had no history of knee injury for at least a few weeks prior to enrolling in the study. 
Each subject participated in a single identical trial.  
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Instrumentation and Measurements 
All experiments were performed in the right knee region with the subject seated in 
a semi-recumbent position in the same laboratory environment with room temperature ( 
SE) of 21.8 ± 0.4˚C and relative humidity of 50%. Prior to the start of data collection, the 
right knee of each subject was instrumented with three laser Doppler flowmetry probes 
(two VP1T/7 and one VP1-HP in conjunction with moorVMS-LDF2 and moorVMS-
LDF1-HP monitor, respectively; Moor Instruments, Millwey, Axminster, Devon, UK) to 
provide a continuous index of cutaneous blood flow. The average penetration depth of 
moorVMS-LDF2 and MoorVMS-LDF1-HP were 0.5 and 2 mm, respectively [59]. 
Thermocouples (Omega Engineering, Stamford, CT) were placed at multiple areas under 
the cooling pad to monitor skin temperature. Perfusion measurements were obtained at 
three different locations: proximolateral, distolateral and proximomedial  to the knee 
joint.  
Following instrumentation placement, the measurement area was carefully 
wrapped with a single layer of loose ACE bandage to provide a thermal barrier between 
the skin surface and the cooling pad (see below). Then a commercially available 
cryotherapy cooling pad (Arctic Ice universal pad; Pain Management Technologies, 
Akron, OH) was applied overlying the instrumented area, and fixed in place using 
another layer of Ace bandage. Figure 5.1A presents an image of instrumentation prior to 
application of the thermal barrier wrap. This figure also shows the general location of the 
various probes in the active treatment area. The Arctic Ice universal cooling pad in place 
is shown in Figure 5.1B.  An Arctic Ice CTU (Pain Management Technologies, Akron, 
OH) was used to deliver cold water through the cooling pad applied to the subject’s right 
knee following the manufacturer’s recommendation (see below for more detail). 
Intermittent blood pressure measurements and heart rate were obtained every 15 minutes 
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by auscultation of the brachial artery with an electrosphygomanometer (SunTech, 
Raleigh, NC), and mean arterial blood pressure (MAP) was calculated as one-third of 
pulse pressure plus diastolic pressure. 
 
 
Figure 5.1.  A sample instrumentation image (A). P1, P2 and P3 mark the three perfusion 
probes, HFG is the heat flux gauge and T marks the location of different thermocouples 
used to measure skin temperature in the knee region. All shown measurements are at 
location that will be covered with the cooling pad.  An image of Arctic Ice cooling pad 
used in our experiments to deliver cold water to the treatment site (B). The cooling pad 
is composed of three flaps, two bigger ones on the sides and a smaller one in the middle 
designed to cover the medial and lateral segment of the joint and patella, respectively. 
Additional thermocouples were placed on the anterior surface of the left shin, 
right thigh, right arm, and chest for monitoring of mean skin temperature using the 
method of Ramanathan [91]. Core temperature was measured via a type T bead 
thermocouple embedded in a single use, silicone ear plug placed at the proximity of the 
tympanic membrane and occluding the ear canal [92–94]. In addition to the laser-Doppler 
flowmetry probes located at the treatment site, two additional probes were located at 
control sites not exposed to the cooling; one on the dorsal surface of the right foot distal 
to the treatment area, and another on the lateral surface of the left knee proximal to the 
joint.  
A B 
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Experimental procedure 
Subjects were in a semi-recumbent position for the duration of the experiment and 
asked to refrain from moving their lower extremities as much as possible to eliminate 
causing motion artifacts in the signal. Subjects were allowed to acclimate to room 
temperature during 1 hour of instrumentation prior to the start of data collection. During 
this time period a blanket was provided if requested to prevent vasoconstriction due to 
exposure to room temperature air. Immediately following instrumentation (including 
placement of the cooling pad) there was a 30 min period of baseline data collection with 
no active change in skin temperature. Next was one hour of skin-surface cooling at the 
treatment site with the CTU circulating water with an average temperature of (±SE) 
2.4°C ± 0.5 through the pad. At the end of the cooling phase the CTU was turned off 
while data collection continued for an additional two hours with all instrumentation in 
place. During this passive rewarming phase heat propagation from the deeper tissue and 
ambient environment increased the tissue temperature. Table 5.1 shows a detailed 
description of these experiments. 
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Durations (min) Baseline Values Minimum Achieved 
Baseline 30.1 ± 0.2 Temperature (˚C) 31.4 ± 0.4 Temperature (˚C) 16.6 ± 0.3 
Cooling 60.1 ± 0.2 
CVC 
Absolute 41.9 ± 8.7 
CVC 
Absolute 8.7 ± 2.0 
Rewarming 123.7 ± 4.7 Relative 100% Relative 26%  3.2 
Table 5.1. Summary of experiments. General information including baseline, cooling and 
rewarming durations and the average CVC and skin temperature values during the last 5 
minutes of baseline and the minimum achieved after 1 hour of cold exposure. The CVC is 
presented both relative to baseline and in absolute format. Standard errors of means for 
all measured values are presented in the table. 
Data extraction / Analysis 
Hemodynamic and thermal data were collected on a data acquisition system 
(National Instruments (NI) input modules 9205, and 9213, National Instruments, Austin, 
TX) which were then subsequently transferred to a laboratory computer via an NI DAQ 
9174 (National Instruments, Austin, TX). All perfusion data were collected with a 
sampling rate of 12 Hz. Temperature data was sampled at the rate of 1 Hz. Three laser 
Doppler flowmetry perfusion probes were used under the cooling pad in each experiment 
to measure skin perfusion. VP1T/7 perfusion probes were also used to measure skin 
temperature at the exact site that perfusion was measured. There was no significant 
difference between the average perfusions measured by VP1T/7 and VP1-HP probe. 
Therefore all perfusion and CVC data presented herein is based on the average values of 
VP1T/7 probes. All reported skin temperatures are the average values of the VP1T/7 
probes. In order to account for potential blood pressure changes during the protocol, all 
blood flow data is reported as cutaneous vascular conductance (CVC) as calculated by 
CVC = Flux units / mean arterial pressure.  
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Data from the cooling and rewarming periods were divided into 1-minute 
segments from the starting point of each phase of a trial. Baseline data was calculated as 
the median value for perfusion and CVC during the last 5 min of the period. Likewise, 
median values for perfusion and CVC were determined during each of the 1 min data 
segments during cooling and rewarming. The same procedure was used to extract 
temperature data with the exception that the median was replaced with mean to calculate 
a representative value for each temporal data segment. This data was used to study 
CVC/skin temperature hysteresis (by visualization and calculation of area, see below). 
All other application data was downsampled to 1 value/5 min. Data extraction was 
performed in MATLAB (MATLAB7.10, The MathWorks Inc., Natick, MA, 2010) in a 
semiautomated fashion with the only input from the researcher being the designation of 
the starting and ending time points of active cooling.  
CVC values were normalized to the baseline period and calculated as percent 
change from that state. The minimum CVC measured during the cold exposure was 
calculated and compared to baseline using a one-sample t-test in MATLAB.  
Persistence of vasoconstriction during the rewarming period 
 A case-control study using the Dunnett’s test was performed to compare CVC 
and skin temperature from the first five minutes of rewarming with future time points. 
Additionally, repeated measure ANOVA (rmANOVA) and Freidman tests were used to 
compare CVC values from the first 5 minute of rewarming to that for all other subsequent 
time points. Bonferroni correction and false discovery rate (FDR) control were used to 
adjust the p-value for multiple comparison tests. The modified z-score method was used 
to identify possible outliers [95]. The Shapiro-Wilk’s test was used to assess the 
assumption of data normality at each time point and the Maulchly’s test the assumption 
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of data sphericity. Mixed model regression (MMR) was used to evaluate the possible 
increasing trend in CVC during rewarming and its statistical significance. MMR was 
applied for this purpose rather than linear regression due to the repeated measure nature 
of the data, which could potentially violate the assumption of independence in linear 
regression. SPSS (IBM SPSS Version 21.0 for Windows; Armonk, NY: IBM Corp) was 
used for all statistical analysis with the exception of the one sample t-test and the 
Dunnett’s test [96] which were performed in MATLAB.  
Hysteresis 
MMR was applied to model the change in CVC as a function of skin temperature 
during both the cooling and passive rewarming periods using SPSS. A quadratic term 
(temperature
2
) was added to the standard linear regression equation (intercept + 
temperature) to accommodate the nonlinear behavior of the data. The temperature and 
temperature
2
 were used as  fixed effects to determine the overall trend and as the random 
effect to calculate the variation among different subjects. A dummy variable was 
introduced to differentiate between the cooling and the rewarming portions of the 
experimental cycle. Finally, two interaction terms (the interactions between the dummy 
variable and the temperature and the temperature
2
) were added to the model to verify the 
significance of the differential dependence of CVC on skin temperature during cooling 
and rewarming. The likelihood ratio test for random effects was used to validate the 
significance of different terms in the regression model. The normal quantile-quantile plot 
(Q-Q plot) was used to investigate normality of residuals as a diagnostic measure to 
evaluate the representative accuracy of the MMR model. Significance was accepted at P 
≤ 0.05. 
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RESULTS 
Skin temperature reached an average minimum (± SE) of 16.6˚C ± 0.3 starting 
from a baseline value of 31.4˚C ± 0.4 at the completion of 1 hr of active cooling. At the 
end of cooling, the CVC was reduced significantly from its baseline value (p < 0.001). 
Exemplar data presented in Figure 5.2 show changes in CVC and skin temperature during 
cooling for 60 minutes. The CVC drops by more than 75% of baseline by the end of 
cooling and remains depressed for the duration of data collection. In contrast, the surface 
skin temperature drops by about 14˚C during cooling and increases by about 10˚C during 
the rewarming. This hysteresis between CVC and skin temperature is described in more 
detail below. CVC measurements at control sites do not show a similar decrease in 
response to cooling at the treatment site (data not presented here). 
 
 
Figure 5.2.  Percent change in CVC compared to baseline values (top plots) and skin 
temperature (bottom plots) from 2 different experiments. Each experiment was composed 
of 30 minutes of baseline and 60 minute of cooling follow by about 2 hours of passive 
rewarming. 
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Persistence of vasoconstriction during the rewarming period 
A case-control study applying the Dunnett’s test was used to compare the changes 
in CVC and skin temperature during rewarming. The results show that even though 
temperature had a significant increase starting at 15 minutes into the rewarming period (p 
< 0.0005), the CVC values showed no significant increase throughout the entirety of 
rewarming (n.s.), with the exception of the CVC at 120 min which was significantly 
higher than during the first 5 minutes (p = 0.035).  
The Shapiro-Wilk’s test showed that CVC data at each time point was normally 
distributed (p>0.05), but given our sample size of 6 and the low power of normality tests 
for low sample sizes [79] we performed both rmANOVA and its nonparametric 
counterpart, the Friedman test. SPSS was not able to calculate χ2 statistics and 
significance for the Mauchly’s test but since the estimation of ε was less than 0.75, the 
Greenhouse-Geisser correction was used to assess the significance of rmANOVA. Since 
rmANOVA was statistically significant (p=0.013), a multiple comparison test was 
performed. The results of multiple comparison tests with Bonferroni correction and FDR 
control, and Friedman test are presented in Table 5.2. Multiple comparison tests with 
Bonferroni correction displayed no significant increase in CVC during the rewarming 
period. Multiple comparison tests with the FDR control method indicated a significant 
increase in CVC only at 120 min (p=0.021), whereas the Friedman test showed a 
significant increase after 110min (p=0.048 and 0.04, at 110 and 120 min, respectively).  
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 10 min 20 min 30 min 40 min 50 min 60 min 70 min 80 min 90 min 100 min 110 min 120 min 
rmANOVA with 
Bonferronin adjustment 
n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 
rmANOVA with 
adjusted Bonferroni 
(FDR) 
n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 0.021 
Friedman test n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 0.048 0.040 
Table 5.2. Results of rmANOVA and Friedman tests. Persistence of vasoconstriction resulted from exposure to 15C for 60 
minutes. CVC at different time points during rewarming period are compared to CVC during the first 5 minutes of rewarming. 
Repeated measure ANOVA with Bonferroni and adjusted-Bonferroni (FDR method) adjustment and Friedman tests were used 
for this study. The time points are presented in respect to the start of rewarming period. The values presented are the results of 
pairwise comparison performed in SPSS. All non-significant results are marked as n.s. and the significant p-values are 
expressed numerically and presented in red.
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A mixed model regression study of the CVC rewarming data at first 60, 75, 90, 
105 and 120 min showed that the temporal slope of a fitted line was significantly larger 
than 0 (p < 0.05) only at 90 minutes and later and was insignificant earlier (n.s.). 
Temperature / CVC hysteresis 
The persistence of vasoconstriction results in a hysteresis effect between CVC 
and skin temperature during the cooling and rewarming cycle. Figure 5.3 shows 
temperature and CVC as a function of time during the rewarming period as well as their 
values during baseline and at the end of cooling. Temperature increases immediately 
upon cessation of cooling, whereas perfusion shows a further drop during the first 10 
minutes of rewarming followed by a very slow increase during rewarming. CVC regains 
only about 30% of vasoconstriction on the 120 min of rewarming while temperature 
recovers about 70% of the cooling drop. This hysteresis behavior is seen explicitly in 
Figure 5.4 where CVC is plotted as a function of the skin temperature during cooling 
(black stars) and rewarming (grey dots). Figure 5.4 shows a CVC / Temperature state 
space diagram from a single experiment (A) and the average of all 6 experiments (B). 
Arrows are used to mark the process direction during cooling and rewarming. During 
baseline period, the skin temperature shows a mild increasing trend due to the insulating 
effect of covering the treatment area with the ACE bandage and the cooling pad, but in 
the absence of circulating cold water. Consequently, CVC usually has higher values at 
the start of cooling compared to its initial baseline state, causing the normalized CVC to 
begin from a state larger than 100% in Figure 5.4.  
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Figure 5.3. Temperature (top panel) and absolute CVC (bottom panel) values during the 
last 5 minutes of baseline and cooling (marked as B and C, respectively) and at the end of 
each 10 minute interval during rewarming periods. The represented values are average 
measurements from 6 different experiments. Error bars show the standard errors of the 
mean. The cooling phase of experiments lasted for 60 minutes. 
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Figure 5.4. Skin perfusion as a function of skin temperature during cooling (stars) and 
passive rewarming (dots). The arrows show the direction of time progress. Each two 
subsequent data points are one minute apart from each other.  A hysteresis plot from a 
sample experiment (A). The hysteresis plot based on the average measurements from all 
the experiments (B). 
The area of the space state diagrams was calculated for each experiment, and the 
average determined to be significantly greater than zero (26.0 ± 4.5 (SE), p < 0.005). 
MMR was used to model the change in CVC as a function of skin temperature during 
cooling and passive rewarming. A quadratic equation of the form 
                        
                
            
            
            
 
was used for MMR where T stands for temperature; k is a flag that defines if each 
data point is part of the cooling or rewarming periods;                 are the fixed 
effects coefficients;                . are the random effects coefficients; k, k
*
T and k
*
T
2
 
are the interaction terms; and     is the residual error term. The slopes of the regression 
A B 
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lines fitting CVC to skin temperature data are presented in Table 5.3.  The interaction 
terms (between the flag variable and the linear and the quadratic temperature terms) were 
both significant, implying a significant difference between the two regressions lines. To 
test the validity of the model, likelihood ratio tests were performed and the Q-Q plot of 
residuals was created. The likelihood ratio test showed that the current model was 
significantly better than alternative models with the omission of any or all random effect 
terms. A visual inspection of the Q-Q plot of residuals of the regression fit meets the 
requirement for normality. 
 
 Parameter 
Estimate 
(SE) 
Significance Confidence Interval 
Cooling 
Intercept 
64.05521 
(38.31871) 
0.144 -28.9535 157.064 
Temperature 
-4.77696 
(3.133645) 
0.176 -12.3662 2.812285 
Temperature
2
 
0.15019 
(0.066007) 
0.061 -0.00951 0.30989 
Rewarming 
Intercept 
-216.764 
(38.17361) 
0.001 -309.747 -123.781 
Temperature 
19.31889 
(3.140293) 
0.001 11.73156 26.90622 
Temperature
2
 
-0.27249 
(0.066417) 
0.005 -0.43216 -0.11282 
Table 5.3. Mixed Model Regression results. The coefficients for MMR for the slope 
fitting CVC vs temperature data to a quadratic function are presented for both cooling 
and rewarming periods. 
DISCUSSION 
The goal of this study was to investigate the effect of localized cooling with a 
CTU on skin temperature and CVC at a treatment site. The data show that localized 
cooling induces a pronounced reduction in CVC which is sustained long into a 
subsequent passive rewarming phase, in the absence of any external means to stimulate 
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blood flow. Furthermore, these findings demonstrate that sustained reductions in CVC 
following cooling persist for an extended period of time despite the recovery of skin 
temperature, creating a hysteresis effect between CVC and skin temperature during 
successive active cooling and rewarming. These results extends our prior work that 
demonstrated with many different CTUs a persistence of vasoconstriction during the 
passive rewarming period following localized cooling [73].  
A significant reduction in tissue perfusion was measured using LDF at multiple 
sites for 60 minutes of active cooling with an Arctic Ice CTU. The skin blood perfusion 
showed no significant increase during the first 2 hours of passive rewarming despite a 
significant increase in skin surface temperature. This coupling (during cooling) followed 
by decoupling (during rewarming) of skin temperature and blood perfusion results in a 
hysteresis phenomenon. 
Localized cooling is very well known to cause significant vasoconstriction and 
thus a reduction in tissue perfusion [17,22,86,87,97–100]. The extent of the reduction in 
tissue perfusion during localized cooling varies among studies. For example, Knoblock, 
et al. measured an 86% and 70% reduction in skin perfusion at the depth of 2 mm after 7 
[17] and 30 [22] minutes of localized cooling, whereas Ho, et al. showed only a 25.8% 
reduction in soft tissue perfusion after 20 minutes of cold exposure [97]. Part of this 
discrepancy in results could be related to the measurement methods used or the depth at 
which blood perfusion was studied. Taber, et al. [101] investigated the effect of cold gel 
pack application for 20 minutes on tissue perfusion in the ankle region using impedance 
plethysmography and observed a significant reduction in blood perfusion independent of 
the applied temperature. However, this study utilized a different methodology to assess 
tissue perfusion, and it did not isolate the pressure effect of a gel pack from a 
vasoconstrictive response. 
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There are only a very limited number of studies that investigate the recovery in 
tissue perfusion after termination of active cooling. Yanagisawa, et al. used oxyHb as a 
measure of tissue circulation and showed that perfusion remains significantly depressed 
during the first 78-90 minutes following cooling [100]. This result is similar to findings 
presented in this article. Curl, et al. showed no long-term effect on tissue perfusion after 
cessation of cryotherapy in rat muscle after induction of closed soft tissue injury [86]. We 
believe the difference in the experimental condition and the tissue site evaluated could be 
the reason for the dissimilarity with the results.  
Vuksanovic, et al. showed a similar hysteresis between skin temperature and 
blood perfusion during cooling and rewarming in the forearm region in the approximate 
skin temperature range of 29-38˚C with a cooling rate of 1˚C /min [102]. The current 
study investigates the hysteresis phenomenon at lower temperatures in the knee region 
with an average cooling rate of 0.25˚C /min. A quadratic function in MMR was fit the 
data to accommodate for its conceived concavity and convexity of behavior and to 
demonstrate the hysteresis effect. In a similar but a much simpler approach, Kozelek, et 
al. used a linear regression model to show the existence of hysteresis [103].The observed 
hysteresis between temperature and CVC during cooling and rewarming indicates that the 
system has a memory and that the state of system is not only dependent on its current 
condition but also its history and initial condition thus, there is not a one-to-one 
relationship between tissue temperature and perfusion. Knowing the current value of 
tissue temperature is not sufficient to determine the perfusion state. A preliminary study 
(data not presented here) was undertaken with cooling and rewarming rates of 0.1˚C/min 
to determine whether the hysteresis depends on how rapidly temperature is changing. 
Data showed the hysteresis to remain present even at this reduced cooling rate but there 
was a reduction in the area of the CVC/T plot. This finding indicates that there is a true 
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hysteresis effect that is not simply a product of a delayed response between temperature 
and CVC. Further investigation is proceeding to more fully define the hysteresis during 
cryotherapy. 
The reason for the persistence of vasoconstriction beyond the termination of 
active cooling is not yet understood. It could be associated with a biophysical effect of 
cold exposure or to a humoral agent that is released locally. Further work is needed in 
this area to understand the process for delayed recovery of tissue perfusion subsequent to 
active cooling. Some possible mechanistic explanation includes the release of a humoral 
agent during cooling that prevents vasodilation as skin temperature increases. Localized 
cooling experiments in the forearm region have been shown to cause vasoconstriction via 
mechanisms such as activation of the Rho-Rho kinase pathway [41] and inhibition of the 
nitric oxide system [37]. These experiments are usually performed at higher skin 
temperatures (24˚C) and at different anatomical locations that commonly practiced in 
cryotherapy and do not address the vasoactive response beyond the active cooling period. 
Another possible contributor could be a direct biophysical effect of cold exposure that 
might last beyond the active cooling period.  
There are many examples of hysteresis in biology and physiology [103–105].  
Samples of temperature-driven hysteresis are reported in references [106,107]. Extensive 
review of literature did not identify other thermally-driven hysteresis phenomena in 
biological systems. However, the consistency with which hysteresis between local 
temperature and blood perfusion has been observed in the current cryotherapy trials 
presents a compelling argument for its existence in this system. Given the clinical 
implications of a prolonged state of vasoconstriction, it would appear to be a feature of 
cryotherapy of great importance and well worthy of more extensive study.  
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CONCLUSION 
The skin temperature and CVC responses to localized cooling were studied. Data 
showed a significant decrease in CVC during cooling that persisted well into the 
rewarming period. Furthermore, a hysteresis effect between CVC and skin temperature 
was observed during a tissue cooling and rewarming cycle. The persistence of significant 
reduction in CVC may be a contributing factor in the development of ischemic injury 
processes associated with localized cooling. Further investigation is needed to understand 
the mechanism for the persistence of vasoconstriction during rewarming and the 
hysteresis between CVC and skin temperature. 
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Chapter 6: Conclusion 
This research was focused on investigating the effect of localized cryotherapy on 
skin temperature and perfusion. The first part of the study was performed using 
commercially available CTUs to examine the dynamics of thermal and vascular response 
to localized cooling during and beyond the active cooling phase. The second part of this 
study concentrated on the investigation of the dose-dependent response of tissue 
perfusion to changing skin temperature where both variations in applied temperature and 
duration of application were considered. In addition to studying physiological response to 
skin cooling, the thermal profiles on the cooling pad from multiple CTUs were studied 
and the thermal uniformity of those pads was compared to each other. Since cold-induced 
vasoconstriction is considered a contributing factor for developing ischemic 
complications, methods to stimulate blood flow in tissue was also tested. In addition to 
reducing the chance of complications, intermittent blood flow stimulation might 
accelerate and improve the healing process by providing tissue oxygenation and delivery 
of nutrients and removal of toxic byproducts.  
The results show that localized cooling produces a significant reduction in skin 
perfusion which lasts long after the removal of thermal stimuli independent of the type of 
CTU in use. A small study comparing the effect of localized cooling on knee and 
foot/ankle region showed no significant difference in extent of cold-induced 
vasoconstriction based on the body parts under the investigation. The results of dose-
dependent study shows that a minimal drop in skin temperature by only 4˚C results in a 
significant reduction in skin perfusion and that this reduced skin perfusion further 
amplifies by additional decline of skin temperature. Similar to the previous study, the 
reduction in skin perfusion was shown to last long after cessation of active cooling. 
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Furthermore, a hysteresis response between skin temperature and perfusion was observed 
and compared among different experimental groups (see Appendix A). The outcome of 
this study will be prepared for publication at a future time. The study of thermal 
distribution on the surface of cooling pads associated with multiple CTUs showed a 
varying degree of nonuniformity which was a function of both cooling pad design as well 
as the device type. The nonuniformity of pad surface temperature signifies the 
importance of expressing the pad temperature in a range format as opposed to a single 
representative temperature.  
 Blood flow stimulation methods and results are presented in Appendix B. Three 
different methods to stimulate skin blood flow intermittently were investigated. The 
thermal stimulation was chosen as the method to reliably and reproducibly increase skin 
blood flow. Appendix C provides detailed explanation of the downsampling procedure of 
the raw data and presents data plots from an exemplar experiment.  
Another important observation that I made based on the results of cryotherapy 
experiments was that the skin temperature varied widely in the treatment area and that 
this temperature variation was not necessarily related to temperature variation on the pad 
surface. Skin temperature distribution rather seemed to follow a certain anatomical 
pattern such that skin covering patella always exhibited much colder compared to its 
surroundings in cryotherapy experiment performed in the knee region with patella 
coverage (see Appendix D). Similar behavior was observed the foot cryotherapy 
experiments. This finding suggests that skin temperature measurement at a single point 
could not be a good representative of thermal conditions in the treatment region. 
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Appendix A 
DOSE-DEPENDENCE OF COLD-INDUCED VASOCONSTRICTION 
A set of experiments were designed to study the effect of applied temperature on 
tissue perfusion. The goal of these experiments was to investigate the dose-dependent 
response of tissue perfusion while facing different ranges of applied temperature. A 
Lauda-Brinkmann (LAUDA-Brinkmann, LP, Delran, NJ) water bath in conjunction with 
an Arctic Ice universal cooling pad (Pain Management Technologies, Akron, OH) were 
used to deliver water at desired temperature to the treatment site. The detailed description 
of the controlled skin temperature experiments are presented in Table A.1. These 
experiments were performed in a repeated measure format on 6 healthy adults (3 males), 
age (±SE) 22.5 ± 1.4 y and BMI (±SE) 23.4 ± 1.6 kg/m
2
. There was at least one week of 
separation between two consecutive experiments performed on the same subject. The 
order of experiments remained the same for all subjects. The experiments were 
performed at 4 nominal cooling (27.5, 25, 20, and 15˚C) and one warming temperatures 
(37˚C). The cooling duration for experiments performed at 25 and 20˚C was set to either 
20 or 60 min. For all other cooling or warming experiments, active thermal manipulation 
lasted for 60 min. The instrumentation procedures for these set of experiments follow the 
descriptions provided in Chapter 5. For all experiments, data was collected continuously 
throughout the baseline (30 min), the active cooling/warming (either 20 or 60 min), and 
the rewarming periods (120 min). 
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Experiment 
Baseline 
Duration (min) 
Cooling /warming 
Duration (min) 
Recovery 
Duration (min) 
Skin 
Temperature (C) 
25 C – 60 min 30.2 ± 0.3 60.4 ± 1.4 121.8 ± 1.9 24.7 ± 0.2 
20 C – 60 min 30.2 ± 0.5 60.4 ± 0.3 122.8 ± 3.3 19.8 ± 0.2 
15 C – 60 min 30.1 ± 0.2 60.1 ± 0.2 123.7 ± 4.7 16.6 ± 1.1 
27.5 C – 60 min 30.1 ± 0.2 60.1 ± 0.2 121.8 ± 1.6 27.3 ± 0.1 
37 C – 60 min 30.4 ± 0.5 60 ± 0.2 123.4 ± 2 37.2 ± 0.1 
25 C – 20 min 30.2 ± 0.3 20.1 ± 0.2 123.4 ± 1.7 23.8 ± 0.8 
20 C – 20 min 29.6 ± 1.1 20.3 ± 0.1 122.2 ± 2.4 21.2 ± 1.1 
Table A.1  Skin perfusion caused by change in skin temperature. 
Table A.2 contains information regarding the duration of each active thermal 
manipulation as well as minimum skin temperature and CVC achieved during each of 
these experiments. The temperature values are based on the average of temperature 
measured using P1 and P2 perfusion probes. The presented CVC values are either based 
on the average values measured using P1 and P2 or what was measured using P3. The 
pick detection depth for P1 and P2 is at 0.5 mm and for P3 at about 2 mm. The numbers 
presented are the average values and standard deviations.  
 
Duration ( 
SD) (min) 
Temperature ( SD) 
(C) 
Average CVC Based on 
P1 and P2 
Measurements ( SD) 
(% of Baseline) 
CVC Calculated Based 
on P3 Measurements  
( SD) 
(% of Baseline) 
Baseline 31.2  1.3 100 100 
60.4 ± 1.4 24.7  0.2 53.9  10.5 51.6 ± 11.2 
60.4 ± 0.3 19.8  0.2 31.4  4.8 29.8 ± 7.2 
60.1 ± 0.2 16.6  1.1 26  11.1 24.8 ± 5.2 
60.1 ± 0.2 27.3  0.1 59.7  16.1 56.6 ± 18 
60 ± 0.2 37.2  0.1 414.8  229.8 266.8 ± 81.2 
20.1 ± 0.2 23.8  0.8 46.7  11.4 45.1 ± 21 
20.3 ± 0.1 21.2  1.1 39.1  10.2 43.6 ± 14.1 
Table A.2  Detail information regarding each experimental group. 
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The results of a pairwise comparison between minimum CVC achieved as a result 
of the cooling experiments are presented in Table A.3. The pairwise comparisons were 
made based on the statistics derived from the Friedman test. The significant pairwise 
comparisons are marked with X at a significance level of p≤ 0.05.  
 
EXP 
15 C – 60 
min 
20 C – 60 
min 
25 C – 60 
min 
27.5 C – 
60 min 
20 C – 20 
min 
25 C – 20 
min 
15 C – 60 
min 
  X X   
20 C – 60 
min 
   X   
25 C – 60 
min 
X      
27.5 C – 
60 min 
X X     
20 C – 20 
min 
      
25 C – 20 
min 
      
Table A.3  Results from pairwise comparison based on Friedman test 
 
A case-control study was performed using the Dunnett’s test to investigate the 
persistence of vasoconstriction during the passive rewarming period by comparing the 
CVC values from the first 5 min of rewarming to all other time points. The result showed 
no significant increase in perfusion for all time points and all the experimental groups 
with the exception of 110, 115, and 120 min for cooling to 20ºC for 60 minutes. 
Figure A.1 represents minimum CVC achieved for any given skin temperature 
with the exception of 37˚C where it denotes the maximum CVC. All presented CVC 
values are normalized to the baseline measurements. Data bar representing perfusion with 
skin temperature of 37˚C was excluded from Figure A.1b to improve resolution. The 
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figure shows an increasing trend in the extent of vasoconstriction by further reduction of 
skin temperature implying a dose-dependent response between skin perfusion and 
temperature. Even though a decreasing trend in skin perfusion is observe by lowering 
applied temperature, not all the differences in skin perfusions are significant. As 
mentioned earlier, all significant differences are marked in Table 3.   
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Figure A.1.  Minimum CVC as a function of applied temperature for all cooling and 
heating experiments (A) and cooling only experiments (B). Error bars represent standard 
error of mean for both temperature and CVC. All CVC values are normalized to the 
baseline. 
A 
B 
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Figure A.2 compares the minimum CVCs for cooling skin to nominal values of 20 
or 25˚C lasting for either 20 or 60 min. There was no significant difference in minimum 
CVC at skin temperature of 25ºC when active cooling lasted for either 20 or 60 min.  
When cooling to 20ºC there was a significant difference between the minimum CVCs 
given the two possible duration of active temperature manipulations but there was also a 
significant difference between the applied temperatures therefor no statistical inference 
could be made. 
 
 
Figure A.1.  The effect of cooling duration on minimum CVC based on average 
measurements made by P1 and P2. Error bars represent standard error of mean for both 
temperature and CVC. 
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Figure A.2.  CVC and skin temperature data from a sample cooling experiment (A) and 
the temperature/CVC hysteresis plot related to the same experiment (B). 
A 
B 
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Figure A.3.  The area of CVC/Temperature hysteresis plots as a function of minimum 
CVC for the active cooling (A) and warming (B) experiments. 
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The data plots presented in Figure A.3a show skin temperature and CVC in 
response to localized cooling from an exemplar experiment. This experiment was 
composed of 30 min of baseline, 60 min of cooling, and 120 min of passive rewarming. 
As it can be seen CVC follows the reduction in skin temperature during cooling much 
more closely than its increase during the passive rewarming phase. A plot of CVC vs skin 
temperature during cooling (blue stars) and passive rewarming (red dots) is presented in 
Figure A.3b. The figure shows an evident hysteresis between CVC and skin temperature. 
Similarly, hysteresis plots of CVC vs skin temperature were created for each experiment 
and their areas were calculated. Next the average and standard error for areas of the 
hysteresis plots for each experimental group were computed. Figure A.4a shows the area 
of the hysteresis plots versus the minimum CVC achieved for all cooling experiments and 
Figure A.4b shows the area of the hysteresis plots for the heating experiments across 
different subjects. The area of the hysteresis plots appears to be linearly related to the 
minimum CVC achieved. A similar relationship seems to exist between the area of 
hysteresis plot and the amount of thermal exchange from the skin surface during the 
cooling (Figure A.5) and the applied skin temperature (Figure A.6). Figure A.6 confirms 
a dose dependent response for the area of the hysteresis plots to applied skin temperature. 
The hysteresis between perfusion and skin temperature was also observed at a single 
experiment with gradual skin cooling and rewarming implying that what we are 
measuring is a true hysteresis and not a rate-dependent one. Further experiments are 
needed to evaluate and compare the extent of hysteresis in fast and gradual 
cooling/rewarming scenarios. 
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Figure A.4.  Area of perfusion/temperature hysteresis plots vs differential energy transfer 
per unit area during cooling and rewarming periods. 
 
Figure A. 6  The area of perfusion/temperature hysteresis plots as a function of applied 
temperature. 
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Appendix B 
METHODS TO STIMULATE BLOOD FLOW IN SKIN AT A VASOCONSTRICTED STATE 
The goal of this study was to stimulate blood flow in skin following a cooling 
session and after vasoconstriction has taken place. Different methods were used to 
achieve this goal including the application of electrical stimulation to skin in the form of 
TENS or EMS, pneumatic compression (IPC) to ipsilateral foot or leg, or thermal 
stimulation in the form of increasing skin temperature.  
Intermittent pneumatic compression (IPC) devices are commonly prescribed to 
reduce chances of deep vein thrombosis (DVT) and possible thromboembolism. IPCs are 
also used in peripheral arterial disease to improve blood flow. The sequential 
compression of lower extremities improves emptying of veins in the lower extremities 
and an increase pressure differential between arteries and veins, which causes an increase 
in arterial blood flow in the region [108]. Abu-Owen and colleagues reported increase in 
foot skin blood perfusion upon use of IPC in the foot region when subject was in seated 
position [51]. Morgan, et al. suggest that applied shear stress on vascular endothelial cells 
due to compression results in release of endothelial-derived relaxing factor (EDRF) 
which in turn causes relaxation of arterioles and reduced peripheral vascular resistance 
and increased blood flow [109]. 
Transcutaneous electrical nerve stimulation (TENS) and electrical muscle 
stimulation (EMS) function by applying electrical signal to skin surface at or below 
intensities that cause muscle contraction. When the electrical pulse is applied at high 
frequency and low intensities it results in nerve stimulation whereas at low frequency and 
higher intensities causes muscle contraction. TENS is used in management of chronic 
pain. Electrical stimulations in both regimens are used to improve blood flow to the 
tissue. 
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Since the LDF system used for measuring perfusion is laser Doppler based, any 
movements in the measurement area such as those caused by muscle contractions results 
in increase in perfusion signal which could mask any true increases in perfusion. TENS at 
low frequency and high intensity revealed an increase in perfusion signal but it was not 
possible to distinguish the increase in signal due to true increase in skin perfusion from 
and increase caused by movement resulted from muscle contraction therefore no 
conclusion on the effectiveness of using electrical stimulation in increasing tissue 
perfusion at high intensity and low frequency was achieved. No significant increase in 
skin perfusion was observed as the result of electrical stimulation of tissue at other 
frequency/intensity combinations. Similarly, it was impossible to distinguish the source 
of increase in perfusion signal while using IPC on the foot or leg and as such no 
conclusion was made regarding its effectiveness in promoting skin perfusion. Moreover, 
in some occasions no significant increase in perfusion was detected using IPC on either 
foot or leg. Unlike electrical stimulation of tissue or using pneumatic compression on the 
foot or leg which were inconclusive in increasing skin perfusion, thermal stimulation of 
skin successfully resulted in increasing skin perfusion while in a vasoconstrictive state 
following cold application. Furthermore, subsequent cold application showed that the 
skin did not lose its vasoconstrictive capabilities. 
The details for an experiment involving electrical stimulation of tissue are 
presented in Table B.1. In this experiment, the electrical stimulations were applied using 
an LG-TEC combo TENS/EMS unit (LGMedSupply, Cherry Hill, NJ). This experiment 
was composed of 23 excitation events throughout which the electrical pulse intensity, 
duration, frequency or mode were varied. The pulse mode is determined by the shape of 
the pulse and it can be constant over time or applied in bursts (burst mode), have a 
uniform (normal mode) or crescendo-decrescendo profile (SD1 and SD2 modes), or have 
 119 
a frequency/pulse-width modulation (modulation mode). A sample perfusion data for this 
experiment and a picture presenting the waveform of the TENS module are presented in 
Figure B.1. The events marked with numbers 1-7, 19, 20, and 23 were all associated with 
some degree of muscle contractions. All other excitation events took place at lower 
intensities and did not result in a visible change in the perfusion signal. This experiment 
did not include any active change in skin temperature. 
 
Event  Mode Frequency (Hz) Intensity 
#1 Normal  4 6 
#2 Normal  4 6 
#3 Normal  4 6 
#4 Normal  4 5 
#5 Normal  4 4 
#6 Normal  4 4-5 
#7 Normal  4 4-5 
#8 Normal  30 4 
#9 Normal  30 3 
#10 Normal  30 3-4 
#11 Normal  30/ 30 s on 30 s off 3-4 
#12 Normal  150 3-4 
#13 Normal  150/ 15 s on 15 s off 3-4 
#14 Normal 150 4 
#15 Normal  150 4-5 
#16 Burst  5 4 
#17 Burst  0.5 4 
#18 Modulation  150/ 300 4 
#19 Modulation  4/ 300 5 
#20 SD1  4/ 300 6 
#21 SD1  150/ 300 4-5 
#22 SD2  150/ 300 4-5 
#23 SD2  30/ 300 5-6 
Table B.1  Details regarding different episodes of a blood flow stimulation experiment 
using TENS. 
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Figure B.1.  The effect of electrical stimulation on skin perfusion measured at two 
different locations (A) and the waveform of TENS module (B). Numbers and arrows on 
perfusion plots mark the starting point of each stimulation event. The setting of electrical 
stimulation was changed from one event to the next as is described in Table B.1. Each 
excitation event lasted for 3 min with 3 min separation between two consecutive 
episodes.  
A 
B 
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Figure B.2 shows the instrumentation and the results of the leg compression using 
an IPC unit (Kendall SCD Sequel 6325 Compression System; Covidien, Dublin, Ireland). 
Figure B.2 demonstrates the effect of IPC of the leg on skin perfusion in the foot (Figure 
B.2a) and ankle (Figure B.2b) regions downstream to the location of IPC sleeve (knee 
length, Kendall SCD Sleeve 5329; Covidien, Dublin, Ireland). Probe A and B were 
expected to show the differential effect of leg compression on skin blood perfusion in an 
area actively cooled (the foot; probe A) and a control location (the ankle; probe B) were 
no active change in temperature was applied. Neither of the two perfusion probes was 
covered with the IPC sleeve. In Figure B.2 the double arrows delineate the duration of 
each pneumatic compression cycle. Red and green stars represent perfusion during 
cooling and passive rewarming periods, respectively, and each star defines the median of 
perfusion signal for a 5-minute stretch of data straddling the time point it represents. Skin 
perfusion under the cooling pad showed a significant reduction during the cooling phase. 
A similar reduction in perfusion in the control location was not observed. As it can be 
seen perfusion seems to increase while IPC is actively applied but due to aforementioned 
problem in recognizing the source of increase in perfusion signal we were not able to 
make further inferences about the skin perfusion from this data. 
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Figure B.2.  The effect of IPC application on skin perfusion, under the cooling pad (A), 
and in a control location (B) where it was affected by the IPC application but not being 
cooled directly. Instrumentation for the same experiment (C) after the IPC sleeve and the 
perfusion probes were applied, and before the cooling pad was put on. The foot and all 
the instrumentation administered to the foot including the probe A were covered with the 
cooling pad and were actively cooled during the experiment.  
As it was mentioned earlier, thermal stimulation of skin resulted in a significant 
increase in skin perfusion. This increase in skin perfusion was replaced with a reduction 
upon subsequent cooling. Perfusion (top panel) and temperature (bottom panel) data from 
a sample experiment with thermal stimulation is presented in Figure B.3. This experiment 
included three 30-minute long cooling cycles separated by active heating phases lasting 
for 5, 10 and 15 min, respectively. The 10 and 15 min cycles seemed to result in a 
substantial increase in perfusion. Skin resumed its vasoconstrictive state during each cold 
application that follows the active rewarming cycles. 
A B 
C 
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Figure B.3.  A sample active cooling/rewarming experiment 
The results from other active cooling/warming experiments are presented in 
Figures B.4-6 where percent change in skin blood perfusion over time is presented in the 
top panel and the skin temperature in the bottom. The experiment presented in Figure B.4 
included three 30-minutes cooling periods separated by 30-min active warming periods. 
Each of these active warmings resulted in a pronounced increase in skin perfusion such 
that the following cooling periods were not able to resume the extent of vasoconstriction 
achieved during the first cooling. Figure B.5 includes only one heating period which 
lasted for 10 minutes. T1, T2 and T3 represent temperatures measured by P1, P2, and P3 
perfusion probes, respectively. In this study, three of the perfusion probes (P2-4) were 
applied to a region which was exposed to both heating and cooling. P1 perfusion probe 
was used to measure perfusion in an area that was only cooled. During the active 
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warming, T1 shows a slight increase in temperature which is due to parasitic heat transfer 
from the environment and deeper tissue while T2 and T3 show a pronounced increase in 
temperature. Data presented in Figure B.6 shows a similar result to the other studies. In 
this experiment each active warming episode lasted for 4-5 minutes with an active 
cooling of variable duration separating each two consecutive warming. Each warming 
episode increased the skin temperature to its precooling values and caused a prominent 
increase in skin blood perfusion. Thermal stimulation data presented here demonstrates 
the effectiveness of active heating in stimulating skin blood flow. Further study is needed 
to derive any statistical inferences from the data. Furthermore, the onset of the first active 
warming episode in respect to the start of cooling as well as the general duration of each 
episode, the interval and frequency that active warming period should take place, and the 
applied temperatures need to be defined in order to optimize the therapeutic effect of 
active warming. Clinical studies need to be designed to evaluate the effect of thermal 
stimulation in improving the healing process. 
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Figure B.4.  An active cooling and warming experiment with equal durations of heating 
and cooling. 
 
 
Figure B.5.  An active cooling (P1-P4) and warming (P2-P4) experiment. P1 was used as 
a control to isolate the effect of active warming. 
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Figure B.6.  An active cooling and warming experiment with a saw tooth pattern of 
heating 
 127 
Appendix C 
DATA EXTRACTION PROCEDURE 
The procedure for data extraction was described shortly in Chapters 4 and 5. A 
detailed explanation of this procedure is presented below. The first step of data extraction 
is to set the start and end of cooling cycle. This is the only step that a human input is 
needed. These start and end point are manually recorded during each experiment and 
inputted into the body of data processing program and are marked automatically on the 
temperature plot representing the temperature of the cooling pad. An example 
temperature plot is presented below with the start and end point of cooling marked with 
magenta stars (Figure C.1). The 3
rd
 star marks the end point of data collection. The 
person in the charge of data extraction can make corrections by adjusting these points via 
marking the start and end of cooling phase. These adjusted points are represented by 
black squares. The numbers next to each square are its corresponding coordinates where 
x = time (s) and y = temperature (˚C). The second square from the left marks the time 
point where pad temperature seems to reach a steady state. The beginning and end of 
each cooling cycle are marked with magenta-colored stars based on these adjusted 
coordinates on all future data plots. All the future steps are performed by the program 
automatically. First, the perfusion data during the cooling and rewarming cycles are 
divided into 5-min segments and the last 5 min of baseline is also defined. Then the 
median of perfusion for each segment is calculated. The filled circles on all future data 
plots mark the median of perfusion for each data segment. As it can be seen the median 
value is a good identifier of trend in data and is blind to noise. A similar procedure was 
used to extract temperature data with the exception that data segments were each 1-min 
long and that average temperature was used instead of the median to find the 
representative value for each segment. The first black circles from the left on each plot 
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shows the baseline representative value and the other two circles show the global min and 
max value for each quantity. The red and green circles mark the cooling and passive 
rewarming periods, respectively. Data plots presented in this segment are from a 
cryotherapy experiment with 30 min of baseline, 60 min of cooling and 120 min of 
passive rewarming. The P1, P2 and P3 perfusion probes were used to measure perfusion 
under the cooling pad. The perfusion and temperature data measured using these probes 
are presented in Figure C.2-4 and Figure C.7 and C.8. The skin blood perfusion and 
temperature at two control sites was measured using O1 (the contralateral knee; Figure 
C.5 and C.9) and O2 (ipsilateral dorsal foot; Figure C.6 and C.10) perfusion probes.  
 
 
Figure C.1  Cooling pad temperature. The magenta-colored stars from left to right mark 
the start and the end of the cooling phase and the end of data collection. The locations of 
the stars are based on times recorded while running the experiment. The black squares 
from left to right mark the start of cooling, start of steady state for the pad temperature, 
the end of cooling, and the end of data collection. The numbers next to each square show 
the time (s) and temperature (ºC) at that point. The locations of the black squares are set 
by the user. 
0 2000 4000 6000 8000 10000 12000
5
10
15
20
25
30
35
X: 1825
Y: 31.77
Time (s)
T
e
m
p
e
ra
tu
re
 (
C
)
Pad Temperature - 04292013
X: 2271
Y: 8.199 X: 5423
Y: 7.314
X: 1.296e+004
Y: 31.11
 129 
 
Figure C.2  P1 verification plot. The circles define the perfusion values at each point. The 
stars, from left to right, mark the beginning, and end of cooling, and end of data 
collection. Black circles are represent baseline, and the global minima and maxima. Red 
and green circles are from extracted perfusion values from the cooling and rewarming 
period. 12data points = 1 s 
 
Figure C.3  P2 verification plot. Please refer to caption for Figure C.2 for details. 
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Figure C.4  P3 verification plot. Please refer to caption for Figure C.2 for details. 
 
Figure C.5  O1 verification plot. Please refer to caption for Figure C.2 for details. 
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Figure C.6  O2 verification plot. Please refer to caption for Figure C.2 for details. 
 
Figure C.7  The verification plot for temperature measured by P1 perfusion probe. Please 
refer to caption for Figure C.2 for details. 
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Figure C.8  The verification plot for temperature measured by P2 perfusion probe. Please 
refer to caption for Figure C.2 for details. 
 
Figure C.9  The verification plot for temperature measured by O1 perfusion probe. Please 
refer to caption for Figure C.2 for details. 
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Figure C.10  The verification plot for temperature measured by O2 perfusion probe. 
Please refer to caption for Figure C.2 for details. 
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Appendix D 
NON-UNIFORMITY OF SKIN TEMPERATURE UNDER THE COOLING PAD 
The measurements of skin temperature in response to localized cooling 
demonstrated a substantial non-uniformity of skin temperature which did not follow the 
pattern of cooling on the cooling pad such that the coldest area on the skin did not follow 
the coldest region on the pad. More importantly, the highest and coldest area on the skin 
were significantly different from each other.  
Concurrent measurement of skin temperature using IR imaging and thermocouple 
readings  
Figure D.1-3 present information regarding knee skin following a 60-min long 
cooling experiment using EBI cryotherapy unit (EBI, LLC., Parsippany, NJ ) and square 
cooling pad. The experimental protocol and instrumentation were similar to those 
described in Chapter 4 and 5. The skin temperature measurements were made at multiple 
locations on the patella and around the knee. The skin was covered with an insulation 
layer underneath the cooling pad. Figure D.1 shows the temporal variation of skin 
temperature at multiple anatomical locations. Around 80 min into the experiment, cooling 
pad was removed and shortly after repositioned in the same region resulting in a 
disturbance in skin temperature pattern. The temperature plot shows roughly 15˚C 
temperature variation between different sites where temperature was measured.  
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 Figure D.1.  The localization of thermocouples (a) and temporal profile of skin 
temperature measured by different thermocouples (b). Data plot related to some of the 
thermocouples positioned on patella are plotted with higher line thickness for easier 
identification. For the same reason, some of plots related to the more peripheral 
thermocouples are marked with dashed line. 
B 
A 
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At the end of cooling period the cooling pad and the insulation layer were 
removed to visualize skin and capture IR image. The temperature difference between 
measurements made by thermocouples (Figure D.1b) and the IR image (Figure D.2A and 
D.3A) could be due to the time difference between when the measurements were made. 
Acquiring IR images necessitates removal of the cooling pad and the insulating layer 
which exposes the treatment area to the ambient temperature. The longer the exposure to 
the ambient temperature before capturing IR images the higher the difference between the 
thermocouple readings and IR measurements. Figure D.2b shows minimum skin 
temperature at different position on the skin measured by thermocouples and Figure D.2a 
shows an IR image of the same region. Similarly, Figure D.3a and b show the IR image 
and minimum skin temperature from the lateral aspect of the cooling region. All 
presented IR images contain a pseudocolor bar showing the range of temperature in the 
image. 
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Figure D. 2.  The skin temperature in the treatment region at the end of cooling from the 
frontal aspect using IR imaging (a) and thermocouple readings (b). The thermocouple 
measurements show minimum temperature measured at each location. 
A 
B 
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Figure D. 3.  The skin temperature in the treatment area from the later aspect using IR 
imaging (A) and thermocouple measurements (B). The thermocouple readings show 
minimum temperature measured at each location. 
A 
 
B 
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Figure D.4 and D.5 represent temperature data from a 150-min long cryotherapy 
experiment using EBI cryotherapy unit and U-shaped cooling pad. This pad is designed 
such that it covers the medial, proximal and lateral regions of the knee without covering 
patella or the frontal aspect of the shin distal to patella. The disturbance in temperature 
data about 100 min into the experiment is due to the repositioning of the cooling pad. The 
temperature data plot (Figure D.4a) is based on measurements using thermocouples and 
shows more than 10˚C temperature variations between different points in the treatment 
region. The locations of thermocouples are marked in Figure D.4b. The thermocouples 
measuring the least amount of drop in temperature (6-9˚C) during cooling are not directly 
under the cooling pad but are surrounded by it from at least two sides (T14, 9 and 30). 
T13 was positioned under the edge of the cooling pad and therefore was cooled 
marginally. Moreover, the temperature measured by these thermocouples have not 
reached the steady state throughout the cooling cycle and given a longer exposure time in 
many cryotherapy practices, lower temperature reading in areas surrounded by the 
cooling pad but not necessarily covered by it should be expected. The skin temperature 
measured via IR imaging is presented in Figure D.5 where data cursors 1, 2, and 3 mark 
locations proximal, and medial to the patella and on the center of the patella with the 
temperature at these locations being presented below the IR image.  
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Figure D. 4.  The Skin temperature at different locations surrounding the knee during an 
EBI cryotherapy experiment using the U-shaped pad (a). The disturbance in temperature 
data is due to repositioning of the cooling pad.  The optical image shows the location of 
thermocouples (b). 
A 
B 
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Figure D. 5.  IR image of knee undergoing cryotherapy. The image shows the superficial 
temperature distribution. This images has a similar orientation to the optical one in Figure 
D.4b. Cursor 3 marks a point on the patella. Cursors 1 and 2 mark regions proximal and 
medial to patella that undergo direct cooling. Temperature information regarding these 
three cursors is presented below the IR image. 
Evaluating variation in skin temperature following cryotherapy 
In experiments presented in the Appendix A skin temperature was measured 
continuously at multiple anatomical locations, five on the patella and four on the four 
quadrants surrounding the knee, using multiple type T bead thermocouples. To 
investigate the statistical significance of temperature variability in the knee region during 
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a cryotherapy experiments, the minimum temperature during the cooling cycle was 
extracted at each of these positions and the minimum temperature on patella was 
compared to the temperature from the regions surrounding the knee using the Dunnett’s 
test. The p-value for each of the tests is presented in the Table D.1. In this table, region 1-
4 each designate one of the quadrants surrounding the knee. The statistically significant 
test results are marked in red for easier identification. In the case of cooling to 25 or 15˚C 
for 60 min, one of the thermocouples was not in use for at least one of the subjects and 
therefore was eliminated from the study. Hence no p-value is presented in the table for 
that specific thermocouple. As the results of the Dunnett’s test show, the temperature on 
patella is significantly lower than that of regions farther away from patella. This 
temperature difference is independent of temperature profile on the cooling pad.  
 
Experiment Region 1 Region 2 Region 3 Region 4 
2560 0.0187 0.0547 0.0019  
2060 0.0081 0.00003 0.0002 
0.0159 
1560 0.0491 0.0124 0.0203  
2760 0.0004 0.0022 0.0016 0.00004 
2520 0.0220 0.0002 0.0044 0.0012 
2020 0.0162 0.0161 0.0182 0.0764 
3760 0.0430 0.0169 0.1022 0.0272 
Table D. 1.  The p-values resulted from the case control study comparing the minimum 
patellar temperature compared to the surrounding knee area. Case-control study was 
performed using the Dunnett's test. The statistically significant differences are marked in 
red. 
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The minimum representative patellar temperature (circle) and the average 
(square) and the maximum (star) temperature in regions 1-4 at the end of cooling for each 
experimental group are presented in Figure D.6. As it can be seen the patella temperature 
is always lower than that of surrounding regions and the difference in temperature 
between patella and the other regions are higher when skin is cooled to lower 
temperatures.  
 
Figure D. 6. The difference between minimum patellar temperatures and the maximum 
temperatures in surrounding regions of the knee for each of the experimental groups. The 
first 2 digits for X-axis tics are the nominal skin temperature at the end of cooling and the 
last 2 are the duration of active cooling/ warming. Circle = minimum patellar 
temperature, Square = average surrounding temperatures, Star = maximum surrounding 
temperature. 
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